Thomas Aloia

Compagnon depuis 2017

CURRICULUM VITAE Thomas A. Aloia, M.D., F.A.C.S.

PRESENT TITLE AND AFFILIATION

Primary Appointment Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX Dual/Joint/Adjunct Appointment N/A

CITIZENSHIP United States

OFFICE ADDRESS The University of Texas MD Anderson Cancer Center P. O. Box 3014202 Unit Number: 1484 Houston, TX 77230-1402 Phone: 713-792-4231 Fax: 713-745-6287 Email: taaloia@mdanderson.org

EDUCATION

Degree-Granting Education Cornell University, Ithaca, NY, BA, 1992, Biological Sciences University of California-Los Angeles School of Medicine, Los Angeles, CA, MD, 1996, Medicine Jessie H. Jones Graduate School of Business, Rice University, Houston, TX, Certificate, 2010, Medical and Healthcare Management Harvard School of Public Health, Boston, MA, MBA, Master in Healthcare Management, 2019, Healthcare Management Postgraduate Training Clinical Internship, General and Thoracic Surgery, Duke University Medical Center, Durham, NC, 7/1996-6/1997 Clinical Residency, General and Thoracic Surgery, Duke University Medical Center, Durham, NC, 7/1997-6/1998 Research Fellowship, Thoracic Oncology Laboratory, Duke University Medical Center, Durham, NC, 7/1998-6/2000 Clinical Residency, General and Thoracic Surgery, Duke University Medical Center, Durham, NC, 7/2000-6/2002 Chief Resident, General and Thoracic Surgery, Duke University Medical Center, Durham, NC, 7/2002-6/2003 Clinical Fellowship, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2003-6/2005 Clinical Fellowship, Liver Transplantation and Hepatobiliary Surgery, Paul Brousse Hospital, Villejuif, France, 7/2005-6/2006 Thomas A. Aloia, M.D., F.A.C.S. Page 2 of 52 Basic Life Support Training, The University of Texas MD Anderson Cancer Center, Houston, TX, 5/2012-3/2018 Executive Education, Value Measurement in Health Care Course, Harvard Business School, Boston, MA, 5/2013-5/2013 3rd Annual Mid-Career Academic Surgery Professional Development Course, Society of University Surgeons, Las Vegas, NV, 2/2015-2/2015 ACS Ultrasound for Surgeons Certification, National Ultrasound Foundation (NUF) Ultrasound in Surgery Instructor Certification, Houston, TX, 3/2015-8/2015 2nd Annual Clinical Trial Methods & Design Workshop for Junior Faculty, The University of Texas MD Anderson Cancer Center, Houston, TX, 5/2015-5/2015 Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/2017-6/2017

 

EXPERIENCE/SERVICE

Academic Appointments Associate Professor, Division of Surgery, Medical University of Paris-South, Paris, France, 7/2005-6/2006 Assistant Professor, Surgery, Baylor College of Medicine Michael E. DeBakey Department of Surgery, Houston, TX, 7/2006-6/2007 Assistant Professor, Surgery, Weill-Cornell Medical College Department of Surgery, Houston, TX, 7/2007-10/2010 Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 11/2010-8/2013 Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2013-present Administrative Appointments/Responsibilities Surgeon Champion, The Methodist Hospital NSQIP Program, Houston, TX, 2009-2011 Member, LifeGift Medical Advisory Committee, Houston, TX, 2010-2011 Surgeon Champion, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center NSQIP Program, Houston, TX, 2011-present Program Director, Hepato-Pancreato-Biliary Surgery Fellowship Program, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, 7/2012-present Associate Medical Director, Gastrointestinal Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2013-present Deputy Chair for Education, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2014-6/2017 Thomas A. Aloia, M.D., F.A.C.S. Page 3 of 52 Program Director, International Surgical Oncology Fellowship Program, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2014-present Surgery Special Assistant for Quality, Division of Surgery, The University of Texas MD Anderson Cancer Center, Physicians Network, Houston, TX, 6/2014-present Director of Quality and Outcomes, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2014-present Associate Head, Institute for Cancer Care Innovation, Department of Surgical Oncology, Division of Ofc/EVP, Physician-in-Chief, The University of Texas MD Anderson Cancer Center, Houston, TX, 5/2016-6/2017 Division Quality Officer, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2016-present Head, Institute for Cancer Center Innovation, Department of Surgical Oncology, Division of Ofc/EVP, Physician-in-Chief, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2017-present Executive Director of Cancer Network Quality, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2/2018-present Other Appointments/Responsibilities Instructor in Surgery, Baylor College of Medicine/Ben Taub General Hospital, Houston, TX, 7/2003-6/2006 Instructor in Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2005- 6/2006 Attending Surgeon, Texas Children’s Hospital, Houston, TX, 7/2006-6/2007 Attending Surgeon, St. Luke’s Episcopal Hospital, Houston, TX, 7/2006-6/2007 Attending Surgeon, Ben Taub General Hospital, Houston, TX, 7/2006-6/2008 Attending Surgeon, The Methodist Hospital, Houston, TX, 7/2006-10/2010 Endowed Positions N/A Consultantships N/A Military or Other Governmental Service N/A Institutional Committee Activities Duke University Medical Center Institutional Committee for Graduate Medical Education, Member, 2000-2003 The University of Texas MD Anderson Cancer Center Institutional Committee for Graduate Medical Education, Curriculum Sub-committee, Member, 2003-2005 Baylor College of Medicine Information Technology Hospital Advisory Committee, Member, 2006- 2007 Houston Methodist Hospital Transplant CMPI Committee, Member, 2008-2011 Houston Methodist Hospital Operating Room CMPI Committee, Member, 2008-2011 Houston Methodist Hospital Cancer Care CMPI Committee, Member, 2008-2011 Houston Methodist Hospital Physicians Organization Quality Committee, Member, 2009-2011 Houston Methodist Hospital Alliance for Quality Improvement Committee, Member, 2009-2011 Houston Methodist Hospital Amyloidosis Working Group, Member, 2009-2011 Thomas A. Aloia, M.D., F.A.C.S. Page 4 of 52 Houston Methodist Hospital New Physician Council on Excellence, Member, 2009-2011 Houston Methodist Hospital Patient Safety CMPI, Committee Chair, 2010-2011 Houston Methodist Hospital PO Electronic Medical Record Committee, Member, 2010-2011 The University of Texas MD Anderson Cancer Center DoS Performance Improvement and Quality Initiatives Committee, Member, 2011-2012 The University of Texas MD Anderson Cancer Center Infection Control Committee, Member, 2011-present The University of Texas MD Anderson Cancer, Quality College Advisory Group, Member, 1/2011- present The University of Texas MD Anderson Cancer Center Physician Steering Committee for the Medicare Electronic Health Record, Provider Ambassador, 11/2011-present The University of Texas MD Anderson Cancer Center, DoS Physician Executive Steering Committee, Physician Ambassador, 12/2011-present The University of Texas MD Anderson Cancer Center Institutional Patient Safety Taskforce, Member, 12/2011-present The University of Texas MD Anderson Cancer Center DoS Surgery Safety Committee, Vice- Chair, 1/2012-12/2013 The University of Texas MD Anderson Cancer Center Medical Record Committee, Member, 1/2012-present The University of Texas MD Anderson Cancer Center Department of Surgical Oncology Grand Rounds, Chair, 7/2012-present The University of Texas MD Anderson Cancer Center Institutional GMEC Committee, Member, 7/2012-present The University of Texas MD Anderson Cancer Center, Medical Quality Planning Committee, Member, 4/2013-present The University of Texas MD Anderson Cancer Center, Innovative Clinical Care Committee, Member, 5/2013-present Texas Medical Center, Surgical Quality Advisory Council, Member, 7/2013-present The University of Texas MD Anderson Cancer Center, Division of Surgery Continuous Quality Improvement (CQI) Committee, Chair, 9/2013-present The University of Texas MD Anderson Cancer Center, EHR Value Measurement Committee, Chair, 11/2013-present The University of Texas MD Anderson Cancer Center, Graduate Medical Education Committee, Budget Subcommittee, Member, 12/2013-present The University of Texas MD Cancer Center, Graduate Medical Education Committee, Budget Subcommittee, Chair, 6/2014-6/2017 The University of Texas MD Anderson Cancer Center, Clinical Education Team, Member, 11/2014-present The University of Texas MD Anderson Cancer Center, Hospital Practice Committee, Member, 2015-present The University of Texas MD Anderson Cancer Center, Quality Operations Team, Member, 2016- present HONORS AND AWARDS Graduation with Distinction in All Subjects, Cornell University, 1992 Alpha Omega Alpha, UCLA School of Medicine, 1995 Thomas A. Aloia, M.D., F.A.C.S. Page 5 of 52 Duke Comprehensive Cancer Center Harry Hutchison Gibson Fellow in Cancer Research, Duke University, 1998-1999 President’s Award: Best Scientific Paper, Southern Thoracic Surgical Association, 1999 Administrative Fellow in Surgical Oncology, The University of Texas MD Anderson Cancer Center, 2004-2005 Trainee Recognition Day Poster Award for Clinical Research, The University of Texas MD Anderson Cancer Center, 2004 Surgical Oncology Fellowship Award for Excellence in Clinical Practice, The University of Texas MD Anderson Cancer Center, 2005 Dyer and Baucum Health Quality Fellowship, The Methodist Hospital, 2009 Karen and Josef E. Fischer International Traveling Fellowship Award for Surgeons in Academic Practice, Society for Surgery of the Alimentary Tract, 2009 Australia New Zealand Traveling Fellowship, American College of Surgeons, 2010 Bayer HealthCare Pharmaceuticals, Inc. Mentor Award, The University of Texas MD Anderson Cancer Center, 2012 J. Bradley Aust Award for Best New Member Paper, Western Surgical Association Annual Meeting, 2012 North South Traveling Fellowship, Americas Hepato-Pancreato-Biliary Association, 2012 Executive of the Year, International Association of Administrative Professionals (IAAP), 2013 President’s Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center, 2013 Radiological Society of North America Education Award, Radiological Society of North America, 2013 Society for Surgery of the Alimentary Tract Best Article Award, Journal of Gastrointestinal Surgery, 2013 Julie and Ben Rogers Award for Excellence in the Area of Patient Care, The University of Texas MD Anderson Cancer Center, 2014 President’s Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center, 2014 Award for Best Poster Presentation, Western Surgical Association Annual Meeting, 2015 Compagnons Hepato-Biliares, Honor Society, Paul Brousse Hospital Alumni, 2015 President’s Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center, 2015 Best Poster Award, Western Surgical Association, 2016 Graphic Design USA 2016 Health and Wellness Design Award, The University of Texas MD Anderson Cancer Center, Division of Surgery Surgical Outcomes, 2016 Outstanding Reviewer, Surgery, Elsevier, 2016 Outstanding Reviewer, European Journal of Surgical Oncology, Elsevier, 2016 Courtenay and R. William Bass Surgical Research Scholarship Mentor Award, Houston Methodist Hospital, 2017 Highest Impact Speaker Award, The University of Texas MD Anderson Cancer Center, Graduate Medical Education (GME) Curriculum, 2017 Emil J Freireich Award for Excellence in Education, The University of Texas MD Anderson Cancer Center Clinical Education Excellence Awards, 2018 RESEARCH Thomas A. Aloia, M.D., F.A.C.S. Page 6 of 52 Grants and Contracts Funded Principal Investigator, Patient Reported Functional Outcomes in Cancer Surgery, The University of Texas MD Anderson Cancer Center Career Development Award, 2/18/2014- 2/18/2019, $200,000 ($40,000/year) Investigator, Improving Recovery after Major Cancer Surgery using Patient-Reported Outcomes, R01CA205146, NIH/NCI, 8/1/2016-7/31/2020, $2,585,590 ($638,160/year) Pending N/A Other N/A Completed Co-Investigator, Cost and Quality of Cancer Surgery, 5-Ro1-CA138640-02, NIH/NCI, 9/1/2011-8/31/2014, $799,958 Not Funded N/A Protocols Funded Collaborator, A Phase II Trail of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed By Concurrent Capecitabine and Radiotherapy In Extrahepatic Cholangiocarcinoma (EHCC), SWOG0809, 2010-present Collaborator, Clinical and technical feasibility of a ultrasuperparamagnetic nanoparticle iron oxide (USPIO)-enhanced magnetic resonance lymph node imaging », 2012-0926, 2012- present Collaborator, Compliance and Complications of Peri-Operative « On-Time » Antibiotic Utilization, 2014-0256, 2014-present Unfunded Co-Principal Investigator, An Analysis of Factors Related to the Detection of Systemic Metastasis in Melanoma Patients with a Positive Sentinel Node Biopsy, RCR03-0907, 2003- 2004 Co-Principal Investigator, Analysis of Clinicopathologic Variables Related to Outcome in Patients Undergoing Upper Extremity Hyperthermic Isolated Limp Perfusion (HILP) for Malignant Melanoma, RCR03-0770, 2003-2004 Co-Principal Investigator, Analysis of factors influencing the administration of adjuvant chemoradiotherapy to patients undergoing pancreaticoduodenectomy who were not preoperatively treated, RCR04-0420, 2004-2006 Collaborator, A Phase I Clinical Trial of Hepatic Arterial Infusion of Oxaliplatin, Oral Capecitabine, with or without Systemic Bevacizumab for Patients with Advanced Cancer Metastatic to the Liver, 2010-0413, 2010-present Collaborator, Utility of Post-Gd-EOB-DTPA Mr Imaging in Prediction of Compensatory hypertrophy of the Liver Following Portal Vein Embolization (PVE), 2011-0279, 2011-2015 Principal Investigator, Analysis of Risk Factors for Postoperative Morbidity and Mortality Following Cancer Surgery, PA11-1023, 2011-present Collaborator, Noninvasive Assessment of Tumor Mutation Status in Circulating Free DNA in Metastatic Colorectal Cancer, LAB10-0340, 2011-present Collaborator, Review of Eovist in the diagnosis and detection of primary and secondary liver tumors, DR11-0020, 2011-present Thomas A. Aloia, M.D., F.A.C.S. Page 7 of 52 Principal Investigator, Hepatic epithelioid hemangioendothelioma: A multi-institutional study of treatment and long term outcome, PA11-1077, 2012-2013 Co-Principal Investigator, Postoperative hemodynamics in patients receiving epidural analgesia after hepatic resection, PA12-0103, 2012-2014 Collaborator, Collection of Residual Tissue and Blood for Analyses from Patients with Biliary Tract Cancers, PA11-0826, PI – Rachna Shroff, 2012-present Patents and Technology Licenses Patents N/A Technology Licenses N/A Grant Reviewer/Service on Study Sections Young Investigator Award, Society of University Surgeons, Grant Reviewer, 2014-2016 Resident Research Scholar Award, Society of University Surgeons, Grant Reviewer, 2014-2017 Clinical Investigator Award, Society of Surgical Oncology, Grant Reviewer, 2014-2019 Young Investigator Award, Society of Surgical Oncology, Grant Reviewer, 2014-2019 Thomas DeMeester Traveling Fellowship, Society for Surgery of the Alimentary Tract, Reviewer, 2015 Joseph Fischer Traveling Fellowship, Society for Surgery of the Alimentary Tract, Reviewer, 2016 Writers Workshop Scholarship, Society for Surgery of the Alimentary Tract, Reviewer, 2016 Career Development Award, Society of Surgical Oncology, Grant Reviewer, 2016-2019 PUBLICATIONS Peer-Reviewed Original Research Articles 1. Aloia TA, McFadden DW. Candida in pancreatic infection: a clinical experience. The American Surgeon 60:793-96, 1994. 2. Liu CD, Aloia TA, McFadden DW. A Potential proabsorptive enteric hormone in the treatment of colonic malabsorptive disorders. The American Surgeon 62:232-6, 1996. 3. D’Amico TA, Aloia TA, Moore MB, Herndon JE, Brooks KR, Lau Cl, Harpole DH. Molecular biologic substaging of stage I lung cancer according to gender and histology. Ann Thoracic Surg 69:882-6, 2000. 4. Aloia TA, Harpole DH, Reed CE, Allegra C, Moore MB, Herndon JE, D’Amico TA. Tumor marker expression is predictive of survival in patients with esophageal cancer. Ann Thorac Surg 72(3):859-66, 9/2001. PMID: 11565671. 5. Marom EM, Aloia TA, Moore MB, Hara M, Herndon JE, Harpole DH, Goodman PC, Patz EF. Correlation of FDG-PET Imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer 33:99-107, 2001. 6. Aloia TA, Bepler G, Harpole D, Goodman P, McAdams P, Erasmus J, Herndon J, Patz E. Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities. Cancer Detect Prev 25:336-43, 2001. 7. D’Amico TA, Aloia TA, Moore MB, Conlon DH, Herndon JE, Kinch MS, Harpole DH. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg 72:1144-8, 2001. 8. Harpole DH, Moore MB, Herndon JE, Aloia TA, D’Amico TA, Sporn T, Parr A, Linoila I, Allegra C. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clin Cancer Res 7:562-9, 2001. 9. Cheng TY, Grubbs E, Abdul-Wahab O, Leu SY, Hung CF, Petros W, Aloia TA, Fedrau R, Pruitt S, Colvin M, Friedman H, Tyler D. Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion. Am J Surg 186(5):460-7, 11/2003. PMID: 14599607. Thomas A. Aloia, M.D., F.A.C.S. Page 8 of 52 10. Aloia TA, Gershenwald JE. Management of early-stage cutaneous melanoma. Curr Probl Surg 42(7):460-534, 7/2005. PMID: 16099230. 11. Aloia TA, Zorzi D, Abdalla EK, Vauthey JN. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 242(2):172-7, 8/2005. PMCID: PMC1357721. 12. Aloia TA, Grubbs E, Onaitis M, Mosca PJ, Cheng TY, Seigler H, Tyler DS. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response. Arch Surg 140(11):1115-20, 11/2005. PMID: 16301451. 13. Pawlik TM, Zorzi D, Abdalla EK, Clary BM, Gershenwald JE, Ross MI, Aloia TA, Curley SA, Camacho LH, Capussotti L, Elias D, Vauthey JN. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 13(5):712-20, 5/2006. e-Pub 3/2006. PMID: 16538410. 14. Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141(5):460-6, 5/2006. PMID: 16702517. 15. Aloia TA, Gershenwald JE, Andtbacka RH, Johnson MM, Schacherer CW, Ng CS, Cormier JN, Lee JE, Ross MI, Mansfield PF. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph nodepositive melanoma. J Clin Oncol 24(18):2858-65, 6/2006. PMID: 16782925. 16. Adam R, Chiche L, Aloia TA, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J, Mantion G, Mentha G, Association Française de Chirurgie. Hepatic resection for non-colorectal non-endocrine liver metastases: analysis of 1452 patients and development of a prognostic model. Ann Surg 244(4):524-35, 10/2006. PMCID: PMC1856551. 17. Aloia TA, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S, Azoulay D, Bismuth H, Castaing D, Adam R. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24(31):4983-90, 11/2006. PMID: 17075116. 18. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244(6):897-907, 12/2006. PMCID: PMC1856635. 19. Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D. Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. HPB (Oxford) 8(2):100-5, 2006. PMCID: PMC2131423. 20. Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Abbruzzese JL, Crane CH, Evans DB, Pisters PW. Delayed Recovery after Pancreaticoduodenectomy: A Major Factor Impairing the Delivery of Adjuvant Therapy? J Am Coll Surg 204(3):347-55, 3/2007. PMID: 17324767. 21. Barshes NR, Becker NS, Washburn WK, Halff GA, Aloia TA, Goss JA. Geographic disparities in deceased donor liver transplantation within a single UNOS region. Liver Transpl 13(5):747-51, 5/2007. PMID: 17457866. 22. Aloia TA, Charnsangavej C, Faria S, Ribero D, Abdalla EK, Vauthey JN, Curley SA. Highresolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193(6):702-6, 6/2007. PMID: 17512280. 23. Vibert E, Azoulay D, Aloia TA, Pascal G, Veilhan LA, Adam R, Samuel D, Castaing D. Therapeutic strategies in symptomatic portal biliopathy. Ann Surg 246(1):97-104, 7/2007. PMCID: PMC1899217. 24. Aloia TA, Adam R, Samuel D, Azoulay D, Castaing D. A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation. J Gastrointest Surg 11(10):1328-32, 10/2007. e-Pub 8/2007. PMID: 17682827. 25. Adam R, Aloia TA, Lévi F, Wicherts DA, de Haas RJ, Paule B, Bralet MP, Bouchahda M, Machover D, Ducreux M, Castagne V, Azoulay D, Castaing D. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 25(29):4593-602, 10/2007. PMID: 17925554. Thomas A. Aloia, M.D., F.A.C.S. Page 9 of 52 26. Aloia TA, de Haas RJ, Wicherts DA, Sebagh M, Levi F, Adam R. Hepatic toxicity following systemic chemotherapy in a 65-year old male with colorectal liver metastases. Am J Clin Oncol 6:223-6, 2007. 27. Rodriguez JA, Becker NS, O’Mahony CA, Goss JA, Aloia TA. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg 12(1):110-6, 1/2008. e-Pub 8/2007. PMID: 17710508. 28. Fischer CP, Bass B, Fahy B, Aloia T. Transampullary pancreatic duct stenting decreases pancreatic fistula rate following left pancreatectomy. Hepatogastroenterology 55(81):244-8, Jan-Feb, 1/2008. PMID: 18507117. 29. Adam R, Wicherts DA, de Haas RJ, Aloia TA, Lévi F, Paule B, Guettier C, Kunstlinger F, Delvart V, Azoulay D, Castaing D. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26(10):1635-41, 4/2008. PMID: 18375892. 30. Aloia TA, Fahy BN. A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases. Clin Colorectal Cancer 7(3):197-201, 5/2008. PMID: 18621638. 31. Chirica M, Scatton O, Massault PP, Aloia TA, Randone B, Dousset B, Legmann P, Soubrane O. Treatment of stage IV a hepatocellular carcinoma: Should we reappraise the role of surgery? Arch Surg 143(6):538-43, 6/2008. PMID: 18559745. 32. Short MN, Aloia TA, Ho V. Certificate of need regulations and the availability and use of cancer resections. Ann Surg Oncol 15(7):1837-45, 7/2008. e-Pub 5/2008. PMID: 18459008. 33. Ho V, Aloia TA. Hospital volume, surgeon volume, and patient costs for cancer surgery. Med Care 46(7):718-25, 7/2008. PMID: 18580391. 34. Becker NS, Barshes NR, Aloia TA, Nguyen T, Rojo J, Rodriguez JA, O’Mahony CA, Karpen SJ, Goss JA. Analysis of recent pediatric orthotopic liver transplantation outcomes indicates that allograft type is no longer a predictor of survivals. Liver Transpl 14(8):1125-32, 8/2008. PMID: 18668684. 35. Adam R, de Haas RJ, Wicherts DA, Aloia TA, Delvart V, Azoulay D, Bismuth H, Castaing D. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 26(22):3672-80, 8/2008. PMID: 18669451. 36. Beasley GM, Petersen RP, Yoo J, McMahon N, Aloia TA, Petros W, Sanders G, Cheng TY, Pruitt SK, Seigler H, Tyler DS. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol 15(8):2195-205, 8/2008. e-Pub 6/2008. PMID: 18528730. 37. Becker NS, Rodriguez JA, Barshes NR, O’Mahony CA, Goss JA, Aloia TA. Outcomes analysis for 280 paitents with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 12:117-22, 2008. 38. Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, Choti MA, Pawlik TM. A Proposed Staging System for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 16(1):14-22, 1/2009. e-Pub 11/2008. PMID: 18987916. 39. Fischer CP, Fahy BN, Aloia TA, Bass BL, Gaber AO, Ghobrial RM. Timing of referral impacts surgical outcomes in patients undergoing repair of bile duct injuries. HPB (Oxford) 11(1):32-37, 2/2009. PMCID: PMC2697860. 40. Aloia TA, Goss JA. A report of outcomes after orthotopic liver transplant with allografts from heparin antibody-positive donors. Exp Clin Transplant 7(1):13-7, 3/2009. PMID: 19364306. 41. Gannon CJ, Izzo F, Aloia TA, Pignata S, Nasti G, Vallone P, Orlando R, Scordino F, Curley SA. Can hepatocellular cancer screening increase the proportion of long-term survivors? Hepatogastroenterology 56(93):1152-56, Jul-Aug, 7/2009. PMID: 19760960. 42. Pitt HA, Kilbane M, Strasberg SM, Pawlik TM, Dixon E, Zyromski NJ, Aloia TA, Henderson JM, Mulvihill SJ. ACS-NSQIP has the potential to create an HPB-NSQIP option. HPB (Oxford) 11(5):405-13, 8/2009. PMCID: PMC2742610. 43. Aloia TA, Barakat O, Connelly J, Haykal N, Michel D, Gaber AO, Ghobrial RM. Gastric radiation enteritis after intra-arterial yttrium-90 microsphere therapy for early stage hepatocellular carcinoma. Exp Clin Transplant 7(3):141-4, 9/2009. PMID: 19715522. Thomas A. Aloia, M.D., F.A.C.S. Page 10 of 52 44. Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J, Gaber AO, Ghobrial RM, Bass BL. Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford) 11(6):510-5, 9/2009. PMCID: PMC2756639. 45. Fahy BN, Aloia TA, Jones SL, Bass BL, Fischer CP. Chemotherapy within 30 days prior to liver resection does not increase postoperative morbidity or mortality. HPB (Oxford) 11(8):645-55, 12/2009. PMCID: PMC2799617. 46. Aloia TA, Hemming A, Schwartz M. Surgical treatment of hepatocellular cancer: expert consensus conference. HPB (Oxford) 12(5):311-12, 6/2010. PMCID: PMC2951817. 47. Aloia TA, Knight R, Gaber AO, Ghobrial RM, Goss JA. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors. Liver Transpl 16(8):950-9, 8/2010. PMID: 20589647. 48. Aloia TA. Predicting adverse outcomes after complex cancer surgery. Ann Surg Oncol 17(9):2260-1, 9/2010. PMCID: PMC2924501. 49. Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN, Aloia TA, Krishnan S, Abbruzzese JL. Clinical and prognostic implications of plasma insulinlike growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol 29(29):3892-9, 10/2011. e-Pub 9/2011. PMCID: PMC3189091. 50. Spinks T, Albright HW, Feeley TW, Walters R, Burke TW, Aloia TA, Bruera E, Buzdar A, Foxhall L, Hui D, Summers B, Rodriguez A, Dubois R, Shine KI. Ensuring quality cancer care: A follow-up review of the Institute of Medicine’s 10 recommendations for improving the quality of cancer care in America. Cancer. e-Pub 11/2011. PMCID: PMC3272132. 51. Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) 13(11):774-82, 11/2011. e-Pub 9/2011. PMCID: PMC3238011. 52. Kaseb AO, Abbruzzese JL, Vauthey JN, Aloia TA, Abdalla EK, Hassan MM, Lin E, Xiao L, El-Deeb AS, Rashid A, Morris JS. I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score. Oncology 80(5-6):373-81, 2011. e-Pub 8/2011. PMCID: PMC3171278. 53. Andreou A, Brouquet A, Bharathy KG, Perrier ND, Abdalla EK, Curley SA, Glanemann M, Seehofer D, Neuhaus P, Vauthey JN, Aloia TA. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery. e- Pub 2/2012. PMID: 22306838. 54. Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S, Chang GJ. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215(2):262-70, 8/2012. e-Pub 5/2012. PMID: 22560316. 55. Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 14(8):506-13, 8/2012. e-Pub 5/2012. PMCID: PMC3406347. 56. Andreou A, Kopetz S, Maru DM, Chen SS, Zimmitti G, Brouquet A, Shindoh J, Curley SA, Garrett C, Overman MJ, Aloia TA, Vauthey JN. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg 256(4):642-50, 10/2012. PMID: 22968062. 57. Vauthey JN, Kopetz S, Aloia TA, Andreou A. KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary. Br J Cancer 107(8):1442-3; author reply 1444, 10/2012. e-Pub 9/2012. PMCID: PMC3494431. 58. Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point before Resection of Hepatic Colorectal Metastases. J Clin Oncol 30(36):4566-72, 12/2012. e-Pub 11/2012. PMCID: PMC3518730. 59. Zimmitti G, Roses RE, Andreou A, Shindoh J, Curley SA, Aloia TA, Vauthey JN. Greater Complexity of Liver Surgery is Not Associated with an Increased Incidence of Liver-Related Thomas A. Aloia, M.D., F.A.C.S. Page 11 of 52 Complications Except for Bile Leak: An Experience with 2,628 Consecutive Resections. J Gastrointest Surg 17(1):57-64; discussion p.64-5, 1/2013. e-Pub 9/2012. PMID: 22956403. 60. Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA, International Cooperative Study Group on Hepatocellular Carcinoma. Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy. J Gastrointest Surg 17(1):66-77, 1/2013. e-Pub 9/2012. PMCID: PMC3880185. 61. Schwarz RE, Abdalla EK, Aloia TA, Vauthey JN. AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases. HPB (Oxford) 15(2):89-90, 2/2013. PMCID: PMC3719913. 62. Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant. JACS 216(2):201-9, 2/2013. e-Pub 12/2012. PMID: 23219349. 63. Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control cnalysis. Ann Surg Oncol 20(2):482-90, 2/2013. e-Pub 8/2012. PMID: 22932858. 64. Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN. Selection for Hepatic Resection of Colorectal Liver Metastases: Expert Consensus Statement. HPB (Oxford) 15(2):91-103, 2/2013. PMID: 23297719. 65. Badgwell BD, Aloia TA, Garrett J, Chedister G, Miner T, Krouse R. Indicators of symptom improvement and survival in in patients with advanced cancer undergoing palliative surgical consultation. J Surg Oncol 107(4):367-71, 3/2013. e-Pub 8/2012. PMID: 22886727. 66. Shindoh J, Andreou A, Aloia TA, Zimmitti G, Lauwers GY, Laurent A, Nagorney DM, Belghiti J, Cherqui D, Poon RT, Kokudo N, Vauthey JN. Microvascular Invasion Does Not Predict Long-Term Survival in Hepatocellular Carcinoma up to 2 cm: Reappraisal of the Staging System for Solitary Tumors. Ann Surg Oncol 20(4):1223-9, 4/2013. e-Pub 11/2012. PMID: 23179993. 67. Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN. Margin Status Remains an Important Determinant of Survival after Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy. Ann Surg 257(6):1079-88, 6/2013. e-Pub 2/2013. PMCID: PMC3654038. 68. Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the Efficacy of Portal Vein Embolization for Patients with Extensive Liver Malignancy and Very Low Future Liver Remnant Volume, Including a Comparison with the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy Approach. J Am Coll Surg 217(1):126-33; discussion 133-4, 7/2013. e-Pub 4/2013. PMCID: PMC3880191. 69. Gaber AO, Moore LW, Aloia TA, Suki WN, Jones SL, Graviss EA, Knight RJ, Bass BL. Cross-sectional and Case-Control Analyses of the Association of Kidney Function Staging With Adverse Postoperative Outcomes in General and Vascular Surgery. Ann Surg 258(1):169-77, 7/2013. e-Pub 3/2013. PMID: 23478526. 70. Frenette CT, Boktour M, Burroughs SG, Kaseb A, Aloia TA, Galati J, Gaber AO, Monsour H, Ghobrial RM. Pre-Transplant Utilization of Sorafenib is Not Associated with Increased Complications after Liver Transplantation. Transpl Int 26(7):734-9, 7/2013. e-Pub 5/2013. PMID: 23701126. 71. Landry CS, Lin HY, Phan A, Charnsangavej C, Abdalla EK, Aloia TA, Nicolas Vauthey J, Katz MH, Yao JC, Fleming JB. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors. World J Surg 37(7):1695-700, 7/2013. PMCID: PMC3881007. 72. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Optimal future liver remnant in patients treated with Thomas A. Aloia, M.D., F.A.C.S. Page 12 of 52 extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 20(8):2493-500, 8/2013. e-Pub 2/2013. PMID: 23377564. 73. Kaseb AO, Shindoh J, Patt YZ, Roses RE, Zimmitti G, Lozano RD, Hassan MM, Hassabo HM, Curley SA, Aloia TA, Abbruzzese JL, Vauthey JN. Modified cisplatin/interferon α- 2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma. Cancer 119(18):3334-42, 9/2013. e-Pub 7/2013. PMCID: PMC3775991. 74. Cho SW, Tzeng CW, Johnston WC, Cassera MA, Newell PH, Hammill CW, Wolf RF, Aloia TA, Hansen PD. Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). HPB (Oxford). e- Pub 9/2013. PMID: 24112766. 75. Tzeng CW, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus postdischarge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) 15(10):773-80, 10/2013. e-Pub 7/2013. PMCID: PMC3791116. 76. Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH. Gastric Bleeding After Radiation Therapy for Intrahepatic Cholangiocarcinoma. Pract Radiat Oncol 3(4):344-8, Oct-Dec, 10/2013. e-Pub 12/2012. PMID: 24674408. 77. Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 201(4):W582-9, 10/2013. PMID: 24059396. 78. Mahajan SN, Ariza-Heredia EJ, Rolston KV, Graviss LS, Feig BW, Aloia TA, Chemaly RF. Perioperative Antimicrobial Prophylaxis for Intra-abdominal Surgery in Patients with Cancer: A Retrospective Study Comparing Ertapenem and Nonertapenem Antibiotics. Ann Surg Oncol. e-Pub 10/2013. PMID: 24114052. 79. Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Radiographic Tumor-Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer. J Gastrointest Surg. e-Pub 10/2013. PMID: 24129826. 80. Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM. RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg 258(4):619-27, 10/2013. PMCID: PMC3856211. 81. Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc 27(11):4026-32, 11/2013. e-Pub 6/2013. PMID: 23765427. 82. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Gupta S, Wallace MJ, Vauthey JN. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. Br J Surg 100(13):1777-83, 12/2013. PMID: 24227364. 83. Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, Capussotti L, Giuliante F, Nuzzo G, Aloia TA. Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg 217(6):1028-37, 12/2013. PMID: 24246619. 84. Short MN, Aloia TA, Ho V. The influence of complications on the costs of complex cancer surgery. Cancer. e-Pub 12/2013. PMID: 24382697. 85. Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia TA, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM. Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma. Oncology 85(4):197-203, 2013. e-Pub 9/2013. PMCID: PMC3913463. 86. Tzeng CW, Katz MH, Fleming JB, Lee JE, Pisters PW, Holmes HM, Varadhachary GR, Wolff RA, Abbruzzese JL, Vauthey JN, Aloia TA. Morbidity and Mortality after Thomas A. Aloia, M.D., F.A.C.S. Page 13 of 52 Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification. J Gastrointest Surg 18(1):146-55; discussion 155-6, 1/2014. e-Pub 10/2013. PMID: 24129825. 87. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Safety and Efficacy of Portal Vein Embolization Before Planned Major or Extended Hepatectomy: An Institutional Experience of 358 Patients. J Gastrointest Surg 18(1):45-51, 1/2014. e-Pub 10/2013. PMID: 24129824. 88. Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival. J Gastrointest Surg 18(1):16-24; discussion 24-5, 1/2014. e-Pub 11/2013. PMID: 24241967. 89. Raoof M, Aloia TA, Vauthey JN, Curley SA. Morbidity and Mortality in 1,174 Patients Undergoing Hepatic Parenchymal Transection Using a Stapler Device. Ann Surg Oncol 21(3):995-1001, 3/2014. e-Pub 11/2013. PMID: 24248530. 90. Huang SY, Aloia TA, Shindoh J, Ensor J, Shaw CM, Loyer EM, Vauthey JN, Wallace MJ. Efficacy and Safety of Portal Vein Embolization for Two-Stage Hepatectomy in Patients with Colorectal Liver Metastasis. J Vasc Interv Radiol 25(4):608-17, 4/2014. e-Pub 12/2013. PMID: 24315549. 91. Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff RT, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I. Molecular Characterization of Gallbladder Cancer using Somatic Mutation Profiling. Hum Pathol 45(4):701-8, 4/2014. e-Pub 11/2013. PMCID: PMC4428571. 92. Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, Aloia TA. Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13 771 NSQIP patients. HPB (Oxford) 16(4):373-83, 4/2014. e-Pub 7/2013. PMCID: PMC3967890. 93. Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford) 16(5):459-68, 5/2014. e-Pub 8/2013. PMCID: PMC4008164. 94. Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford) 16(5):430-8, 5/2014. e- Pub 8/2013. PMCID: PMC4008161. 95. Yoon SS, Aloia TA, Haynes AB, Kambadakone A, Kaur H, Vauthey JN, Ferrone CR, Zhu AX, Wo JY, Crane C, Hong TS. Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy. Pract Radiat Oncol 4(3):167-73, May-Jun, 5/2014. e-Pub 8/2013. PMCID: PMC4003410. 96. Aloia TA. Contemplation versus Documentation Before Surgery. Ann Surg 259(6):1038-40, 6/2014. e-Pub 3/2014. PMID: 24646563. 97. Aloia TA, Cooper A, Shi W, Vauthey JN, Lee JE. Reoperative Surgery: A Critical Risk Factor for Complications Inadequately Captured by Operative Reporting and Coding of Lysis of Adhesions. J Am Coll Surg 219(1):143-50, 7/2014. e-Pub 3/2014. PMID: 24862888. 98. Cooper AB, Holmes HM, des Bordes JK, Fogelman D, Parker NH, Lee JE, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Role of Neoadjuvant Therapy in the Multimodality Treatment of Older Patients with Pancreatic Cancer. J Am Coll Surg 219(1):111-20, 7/2014. e-Pub 3/2014. PMID: 24856952. 99. Thomas RM, Aloia TA, Truty MJ, Tseng WH, Choi EA, Curley SA, Vauthey JN, Abdalla EK. Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford) 16(7):677-85, 7/2014. e-Pub 12/2013. PMCID: PMC4105907. 100. Conrad C, Nedelcu M, Ogiso S, Aloia TA, Vauthey JN, Gayet B. Laparoscopic Intragastric Surgery for Early Gastric Cancer and Gastrointestinal Stromal Tumors. Ann Surg Oncol 21(8):2620, 8/2014. e-Pub 3/2014. PMID: 24647675. Thomas A. Aloia, M.D., F.A.C.S. Page 14 of 52 101. Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): A novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol 110(2):107-14, 8/2014. e-Pub 5/2014. PMID: 24846705. 102. Conrad C, Nedelcu M, Ogiso S, Aloia TA, Vauthey JN, Gayet B. Techniques of intragastric laparoscopic surgery. Surg Endosc. e-Pub 8/2014. PMID: 25106714. 103. Mise Y, Kopetz S, Mehran RJ, Aloia TA, Conrad C, Brudvik KW, Taggart MW, Vauthey JN. Is Complete Liver Resection Without Resection of Synchronous Lung Metastases Justified?. e-Pub 11/2014. 104. Sheu T, Heymach JV, Swisher SG, Rao G, Weinberg JS, Mehran R, McAleer MF, Liao Z, Aloia TA, Gomez DR. Propensity Score-Matched Analysis of Comprehensive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer That Did Not Progress After Front-Line Chemotherapy. Int J Radiat Oncol Biol Phys 90(4):850-7, 11/2014. e-Pub 9/2014. PMID: 25216859. 105. Mise Y, Mehran RJ, Aloia TA, Vauthey JN. Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases. Surgery 156(5):1197-203, 11/2014. e-Pub 6/2014. PMCID: PMC4253649. 106. Mise Y, Aloia TA, Vauthey JN. Liver volumetry in virtual hepatectomy must account for vascular territories. J Am Coll Surg 219(6):1194-5, 12/2014. e-Pub 11/2014. PMID: 25458243. 107. Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia TA, Conrad C, Curley SA, Vierling JM, Jalal P, Raghav K, Wallace M, Rashid A, Abbruzzese JL, Wolff RA, Morris JS. Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma. J Natl Cancer Inst 106(5), 2014. e-Pub 5/2014. PMID: 24815863. 108. Kaseb AO, Shah NN, Hassabo HM, Morris JS, Xiao L, Abaza YM, Soliman K, Lee JS, Vauthey JN, Wallace M, Aloia TA, Curley S, Abbruzzese JL, Hassan MM. Reassessing hepatocellular carcinoma staging in a changing patient population. Oncology 86(2):63-71, 2014. e-Pub 1/2014. PMID: 24401634. 109. Cooper AB, Parmar AD, Riall TS, Hall BL, Katz MH, Aloia TA, Pitt HA. Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates? J Gastrointest Surg 19(1):80-6; discussion 86-7, 1/2015. e-Pub 8/2014. PMCID: PMC4289101. 110. Prescott LS, Aloia TA, Brown AJ, Taylor JS, Munsell MF, Sun CC, Schmeler KM, Levenback CF, Bodurka DC. Perioperative blood transfusion gynecologic oncology surgery: Analysis of the National Surgical Quality Improvement Program Database. Gynecol Oncol 136(1):65-70, 1/2015. e-Pub 11/2014. PMID: 25451693. 111. Mise Y, Aloia TA, Conrad C, Huang SY, Wallace MJ, Vauthey JN. Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy. J Gastrointest Surg 19(1):133-41; discussion 141, 1/2015. e-Pub 8/2014. PMCID: PMC4289088. 112. Mise Y, Zimmitti G, Shindoh J, Kopetz S, Loyer EM, Andreou A, Cooper AB, Kaur H, Aloia TA, Maru DM, Vauthey JN. RAS Mutations Predict Radiologic and Pathologic Response in Patients Treated with Chemotherapy Before Resection of Colorectal Liver Metastases. Ann Surg Oncol 22(3):834-42, 3/2015. e-Pub 9/2014. PMCID: PMC4318708. 113. Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, Javle M, Conrad C, Maru DM, Aoki T, Vigano L, Ribero D, Kokudo N, Capussotti L, Vauthey JN. Tumor Location Is a Strong Predictor of Tumor Progression and Survival in T2 Gallbladder Cancer: An International Multicenter Study. Ann Surg 261(4):733-9, 4/2015. e-Pub 5/2014. PMID: 24854451. 114. Brudvik KW, Patel SH, Roland CL, Conrad C, Torres KE, Hunt KK, Cormier JN, Feig BW, Aloia TA, Vauthey JN. Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. e-Pub 5/2015. 115. Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH. Characterization of Anthropometric Changes that Occur During Thomas A. Aloia, M.D., F.A.C.S. Page 15 of 52 Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Ann Surg Oncol 22(7):2416-23, 7/2015. e-Pub 12/2014. PMID: 25519927. 116. Brudvik KW, Mise Y, Conrad C, Zimmitti G, Aloia TA, Vauthey JN. Definition of Readmission in 3,041 Patients Undergoing Hepatectomy. J Am Coll Surg 221(1):38-46, 7/2015. e-Pub 2/2015. PMCID: PMC4478100. 117. Peungjesada S, Aloia TA, Fox P, Chasen B, Shin S, Baiomy A, Loyer EM. (18)F-FDG Uptake at the Surgical Margin after Hepatic Resection: Patterns of Uptake and Differential Diagnosis. Eur Radiol 25(8):2453-9, 8/2015. e-Pub 2/2015. PMID: 25678079. 118. Day RW, Conrad C, Vauthey JN, Aloia TA. Evaluating surgeon attitudes towards the safety and efficacy of portal vein occlusion and associating liver partition and portal vein ligation: a report of the MALINSA survey. HPB (Oxford). e-Pub 8/2015. PMID: 26255813. 119. Aloia TA, Járufe N, Javle M, Maithel SK, Roa JC, Adsay V, Coimbra FJ, Jarnagin WR. Gallbladder Cancer: expert consensus statement. HPB (Oxford) 17(8):681-90, 8/2015. PMID: 26172135. 120. Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar Cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17(8):691-9, 8/2015. PMID: 26172136. 121. Short MN, Ho V, Aloia TA. Impact of Processes of Care Aimed at Complication Reduction on the Cost of Complex Cancer Surgery. J Surg Oncol 112(6):610-5. e-Pub 9/2015. PMID: 26391328. 122. Day RW, Fielder S, Calhoun J, Kehlet H, Gottumukkala V, Aloia TA. Incomplete reporting of enhanced recovery elements and its impact on achieving quality improvement. Br J Surg. e- Pub 9/2015. PMID: 26364714. 123. Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg 102(10):1175- 83, 9/2015. e-Pub 7/2015. PMID: 26206254. 124. Schwarz L, Bruno M, Parker NH, Prakash L, Mise Y, Lee JE, Vauthey JN, Aloia TA, Conrad C, Fleming JB, Katz MH. Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy. Ann Surg Oncol 22(11):3522-9, 10/2015. e-Pub 2/2015. PMID: 25694246. 125. Day RW, Brudvik KW, Vauthey JN, Conrad C, Gottumukkala V, Chun YS, Katz MH, Fleming JB, Lee JE, Aloia TA. Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. Surgery. e-Pub 11/2015. PMID: 26584854. 126. Mise Y, Vauthey JN, Zimmitti G, Parker NH, Conrad C, Aloia TA, Lee JE, Fleming JB, Katz MH. Ninety-Day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality. Ann Surg 262(6):1071-8, 12/2015. e-Pub 1/2015. PMCID: PMC4633391. 127. Day RW, Cleeland CS, Wang XS, Fielder S, Calhoun J, Conrad C, Vauthey JN, Gottumukkala V, Aloia TA. Patient-Reported Outcomes Accurately Measure the Value of an Enhanced Recovery Program in Liver Surgery. J Am Coll Surg 221(6):1023-1030.e2, 12/2015. e-Pub 10/2015. PMID: 26611799. 128. Conrad C, Schwarz L, Perrier N, Fleming JB, Katz MH, Aloia TA, Vauthey JN, Lee JE. Spleen and splenic vessel preserving distal pancreatectomy for bifocal PNET in a young patient with MEN1. Surg Endosc. e-Pub 12/2015. PMID: 26721691. 129. Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, Kaseb AO, Bishop AJ, Swanick CW, Koay EJ, Thames HD, Hong TS, Das P, Crane CH. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis. J Clin Oncol 34(3):219-26, 1/2016. e-Pub 10/2015. PMID: 26503201. 130. Mise Y, Day RW, Vauthey JN, Brudvik KW, Schwarz L, Prakash L, Parker NH, Katz MH, Conrad C, Lee JE, Fleming JB, Aloia TA. After Pancreatectomy, the « 90 Days from Surgery » Definition Is Superior to the « 30 Days from Discharge » Definition for Capture of Clinically Relevant Readmissions. J Gastrointest Surg 20(1):77-84; discussion 84, 1/2016. e-Pub 10/2015. PMID: 26493976. 131. Day RW, Badgwell BD, Fournier KF, Mansfield PF, Aloia TA. Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy. J Gastrointest Surg 20(1):146-53; discussion 153, 1/2016. e-Pub 9/2015. PMID: 26416411. Thomas A. Aloia, M.D., F.A.C.S. Page 16 of 52 132. Passot G, Odisio BC, Zorzi D, Mahvash A, Gupta S, Wallace MJ, Kim BJ, Yamashita S, Conrad C, Aloia TA, Vauthey JN, Chun YS. Eradication of Missing Liver Metastases After Fiducial Placement. J Gastrointest Surg. e-Pub 1/2016. PMID: 26791387. 133. Ismael HN, Loyer E, Kaur H, Conrad C, Vauthey JN, Aloia TA. Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma. J Gastrointest Surg. e-Pub 1/2016. PMID: 26801328. 134. Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conrad C. Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis: Improves Salvageability and Survival. Ann Surg 263(1):146-52, 1/2016. e-Pub 3/2015. PMID: 25775068. 135. Passot G, Chun YS, Kopetz SE, Zorzi D, Brudvik KW, Kim BJ, Conrad C, Aloia TA, Vauthey JN. Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg. e-Pub 1/2016. PMID: 26968325. 136. Day RW, Fleming J, Katz MH, Grubbs E, Bednarski BK, Lee JE, Aloia TA. Rapid assessment of technical competency: the 8-min suture test. J Surg Res 200(1):46-52, 1/2016. e-Pub 6/2015. PMID: 26276369. 137. Aloia TA, Geerts WH, Clary BM, Day RW, Hemming AW, D’Albuquerque LC, Vollmer CM, Vauthey JN, Toogood GJ. Venous Thromboembolism Prophylaxis in Liver Surgery. J Gastrointest Surg 20(1):221-9, 1/2016. e-Pub 10/2015. PMID: 26489742. 138. Balogh J, Gordon Burroughs S, Boktour M, Patel S, Saharia A, Ochoa RA, McFadden R, Victor DW, Ankoma-Sey V, Galati J, Monsour HP, Fainstein V, Li XC, Grimes KA, Gaber AO, Aloia TA, Ghobrial RM. Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients. Liver Transpl 22(2):163-70, 2/2016. e-Pub 1/2016. PMID: 26515643. 139. Ribeiro HS, Torres OJ, Marques MC, Herman P, Kalil AN, Fernandes Ede S, Oliveira FF, Castro Ldos S, Hanriot R, Oliveira SC, Boff MF, Costa WL, Gil Rde A, Pfiffer TE, Makdissi FF, Rocha Mde S, Amaral PC, Costa LA, Aloia TA. I BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 2: APPROACH TO RESECTABLE METASTASES. Arq Bras Cir Dig 29(1):9-13, 3/2016. PMCID: PMC4851142. 140. Zimmitti G, Soliz J, Aloia TA, Gottumukkala V, Cata JP, Tzeng CW, Vauthey JN. Positive impact of epidural analgesia on oncologic outcomes in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol 23(3):1003-11, 3/2016. e-Pub 10/2015. PMID: 26511261. 141. Passot G, Chun YS, Kopetz SE, Overman MJ, Conrad C, Aloia TA, Vauthey JN. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations. Eur J Surg Oncol. e-Pub 3/2016. PMID: 27358198. 142. Mise Y, Passot G, Wang X, Chen HC, Brudvik KW, Aloia TA, Conrad C, Huang SY, Vauthey JN. A Nomogram to Predict Hypertrophy Liver Segments 2 and 3 After Right Portal Vien Embolization. e-Pub 4/2016. 143. Lewis CM, Aloia TA, Shi W, Martin I, Lai SY, Selber JC, Hessel AC, Hanasono MM, Hutcheson KA, Robb GL, Weber RS. Development and Feasibility of a Specialty-Specific National Surgical Quality Improvement Program (NSQIP), The Head and Neck- Reconstructive Surgery NSQIP. JAMA Otolaryngol Head Neck Surg 142(4):321-7, 4/2016. e- Pub 2/2016. PMID: 26892756. 144. Calhoun J, Gottumukkala V, Aloia TA, Feeley T. Enhanced recovery as a mechanism for demonstrating value creation in healthcare. Clin Nutr ESPEN 12:e45, 4/2016. e-Pub 4/2016. PMID: 28531711. 145. Oldhafer KJ, Stavrou GA, van Gulik TM, Core Group, De Santibanes E, Malago M, Schadde E, Hernandez-Alejandro R, Kokudo N, Aloia TA, Abdalla E, Linecker M, Clavien PA. ALPPS- -Where Do We Stand, Where Do We Go?: Eight Recommendations From the First International Expert Meeting. Ann Surg 263(5):839-41, 5/2016. PMID: 26756771. 146. Yamasaki A, Mise Y, Mise Y, Lee JE, Aloia TA, Katz MH, Chang GJ, Lillemoe KD, Raut CP, Conrad C. Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants. Surgery 159(5):1260-8, 5/2016. e-Pub 12/2015. PMID: 26706609. Thomas A. Aloia, M.D., F.A.C.S. Page 17 of 52 147. Conrad C, Passot G, Katz MH, Fleming JB, Kim M, Chun YS, Aloia TA, Vauthey JN, Lee JE. Laparoscopic Insulinoma Enucleation from the Retro-Pancreatic Neck: A Stepwise Approach. Ann Surg Oncol 23(6):2001, 6/2016. e-Pub 3/2016. PMID: 26960928. 148. Fromer MW, Aloia TA, Gaughan JP, Atabek UM, Spitz FR. The utility of the MELD score in predicting mortality following liver resection for metastasis. Eur J Surg Oncol. e-Pub 6/2016. PMID: 27365199. 149. Ribero D, Zimmitti G, Aloia TA, Shindoh J, Forchino F, Amisano M, Passot G, Ferrero A, Vauthey JN. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg 223(1):87-97, 7/2016. e-Pub 2/2016. PMCID: PMC4925184. 150. Yamashita S, Vauthey JN, Kaseb AO, Aloia TA, Conrad C, Hassan MM, Passot G, Raghav KP, Shama MA, Chun YS. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma. J Gastrointest Surg. e-Pub 7/2016. PMID: 27456016. 151. Schwarz L, Aloia TA, Eng C, Chang GJ, Vauthey JN, Conrad C. Transthoracic Port Placement Increases Safety of Total Laparoscopic Posterior Sectionectomy. Ann Surg Oncol 23(7):2167, 7/2016. e-Pub 2/2016. PMID: 26903047. 152. Taylor JS, Marten CS, Potts KA, Cloutier LM, Cain KE, Fenton SL, Tatum TN, James DA, Myers KN, Hubbs CA, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss LS, Ware KM, Park AK, Aloia TA, Bodurka DC, Levenback CF, Schmeler KM. What Is The Real Rate of Surgical Site Infection? J Oncol Pract. e-Pub 7/2016. PMID: 27460495. 153. Brudvik KW, Mise Y, Chung MH, Chun YS, Kopetz SE, Passot G, Conrad C, Maru DM, Aloia TA, Vauthey JN. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol 23(8):2635-43, 8/2016. e-Pub 3/2016. PMCID: PMC5527830. 154. Tran Cao HS, Phuoc V, Ismael H, Denbo JW, Passot G, Yamashita S, Conrad C, Aloia TA, Vauthey JN. Rate of Organ Space Infection Is Reduced with the Use of an Air Leak Test During Major Hepatectomies. J Gastrointest Surg. e-Pub 8/2016. PMID: 27496092. 155. Prakash L, Bhosale P, Cloyd J, Kim M, Parker N, Yao J, Dasari A, Halperin D, Aloia TA, Lee JE, Vauthey JN, Fleming JB, Katz MH. Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. e-Pub 9/2016. PMID: 27634306. 156. Ismael HN, Denbo J, Cox S, Crane CH, Das P, Krishnan S, Schroff RT, Javle M, Conrad C, Vauthey J, Aloia TA. Biologic mesh spacer placement facilitates safe delivery of doseintense radiation therapy: A novel treatment option for unresectable liver tumors. Eur J Surg Oncol 42(10):1591-6, 10/2016. e-Pub 6/2016. PMID: 27296729. 157. Kim BJ, Aloia TA. An Inexpensive Modified Primary Closure Technique for Class IV (Dirty) Wounds Significantly Decreases Superficial and Deep Surgical Site Infection. J Gastrointest Surg 20(11):1904-1907, 11/2016. e-Pub 5/2016. PMID: 27142634. 158. Odisio BC, Yamashita S, Frota L, Huang SY, Kopetz SE, Ahrar K, Chun YS, Aloia TA, Hicks ME, Gupta S, Vauthey JN. Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection. J Gastrointest Surg. e-Pub 11/2016. PMID: 27882510. 159. Schwarz L, Fleming J, Katz M, Lee J, Aloia TA, Vauthey N, Conrad C. Total Laparoscopic Central Pancreatectomy with Pancreaticogastrostomy for High Risk Cystic Neoplasm. Ann Surg Oncol. e-Pub 11/2016. PMID: 26542586. 160. Koay EJ, Guillaume P, Shroff R, Beavers T, Raghav KP, Conrad C, Chun YS, Aloia TA, Kaseb A, Javle M, Vauthey JN. Local Therapy Reduces the Risk of Liver Failure and Improves Survival in Patients with Intrahepatic Cholangiocarcinoma: a Comprehensive Analysis of 362 Consecutive Patients. e-Pub 12/2016. 161. Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim M, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Varadhachary G, Shroff R, Wolff R, Javle M, Overman MJ, Fogelman D, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. J Gastrointest Surg 20(12):1975-1985, 12/2016. e-Pub 10/2016. PMID: 27730398. Thomas A. Aloia, M.D., F.A.C.S. Page 18 of 52 162. Kim BJ, Caudle AS, Gottumukkala V, Aloia TA. The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): the Role of Enhanced Recovery in the Cancer Journey. Int Anesthesiol Clin 54(4):e33-46, 2016. PMID: 27623128. 163. Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg 21(1):164-174, 1/2017. e-Pub 10/2016. PMID: 27778257. 164. Denbo JW, Yamashita S, Passot G, Egger M, Chun YS, Kopetz SE, Maru D, Brudvik KW, Wei SH, Conrad C, Vauthey JN, Aloia TA. RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg 21(1):68-77, 1/2017. e-Pub 6/2016. PMID: 27334313. 165. Denbo JW, Slack RS, Bruno M, Cloyd JM, Prakash L, Fleming JB, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis. J Gastrointest Surg. e-Pub 1/2017. PMID: 28050766. 166. Passot G, Denbo JW, Yamashita S, Kopetz SE, Chun YS, Maru D, Overman MJ, Brudvik KW, Conrad C, Aloia TA, Vauthey JN. Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection. Surgery 161(2):332-340, 2/2017. e-Pub 8/2016. PMID: 27592215. 167. Odisio BC, Yamashita S, Huang SY, Harmoush S, Kopetz SE, Ahrar K, Shin Chun Y, Conrad C, Aloia TA, Gupta S, Hicks ME, Vauthey JN. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg. e-Pub 2/2017. PMID: 28240361. 168. Yamashita S, Passot G, Aloia TA, Chun YS, Javle M, Lee JE, Vauthey JN, Conrad C. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer. Br J Surg 104(3):267-277, 2/2017. e-Pub 1/2017. PMID: 28052308. 169. Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM. The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol 24(2):362-368, 2/2017. e-Pub 8/2016. PMCID: PMC5557388. 170. Kim BJ, Tzeng CD, Cooper AB, Vauthey JN, Aloia TA. Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications. J Surg Oncol 115(3):337-343, 3/2017. e-Pub 11/2016. PMID: 27807846. 171. Clarke CN, Patel SH, Day RW, George S, Sweeney C, Monetes De Oca GA, Aiss MA, Grubbs EG, Bednarski BK, Lee JE, Bodurka DC, Skibbber JM, Aloia TA. Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee-totrainee patient care handoffs after complex general surgical oncology procedures. Surgery 161(3):869-875, 3/2017. e-Pub 11/2016. PMID: 27825699. 172. Roland CL, Starker LF, Kang Y, Chatterjee D, Estrella J, Rashid A, Katz MH, Aloia TA, Lee JE, Dasari A, Yao JC, Fleming JB. Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection. Surgery 161(3):753-759, 3/2017. e-Pub 11/2016. PMID: 27816207. 173. Yamashita S, Chun YS, Kopetz SE, Maru D, Conrad C, Aloia TA, Vauthey JN. APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases. Ann Surg. e-Pub 4/2017. PMID: 28379870. 174. Mizuno T, Sheth R, Yamamoto M, Kang HS, Yamashita S, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Laparoscopic Glissonean Pedicle Transection (Takasaki) for Negative Fluorescent Counterstaining of Segment 6. Ann Surg Oncol 24(4):1046-1047, 4/2017. e-Pub 12/2016. PMID: 27995453. 175. Kutlu OC, Chan JA, Aloia TA, Chun YS, Kaseb AO, Passot G, Yamashita S, Vauthey JN, Conrad C. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. Cancer 123(10):1817-1827, 5/2017. e-Pub 1/2017. PMID: 28085184. Thomas A. Aloia, M.D., F.A.C.S. Page 19 of 52 176. Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, Song J, Li L, Dagenborg VJ, Fretland ÅA, Røsok B, De Rose AM, Ardito F, Edwin B, Panettieri E, Larocca LM, Yamashita S, Conrad C, Aloia TA, Poston GJ, Bjørnbeth BA, Vauthey JN. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg. e-Pub 5/2017. PMID: 28549012. 177. Yamashita S, Loyer E, Kang HC, Aloia TA, Chun YS, Mehran RJ, Eng C, Lee JE, Vauthey JN, Conrad C. Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery. Ann Surg Oncol 24(5):1376-1377, 5/2017. e-Pub 11/2016. PMID: 27878479. 178. Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, Koay EJ. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol 4:39-45, 6/2017. e-Pub 6/2017. PMCID: PMC5833919. 179. Yamashita S, Odisio BC, Huang SY, Kopetz SE, Ahrar K, Chun YS, Conrad C, Aloia TA, Gupta S, Harmoush S, Hicks ME, Vauthey JN. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases. Eur J Surg Oncol 43(6):1040-1049, 6/2017. e-Pub 1/2017. PMID: 28187878. 180. Vega EA, Vinuela E, Yamashita S, Sanhueza M, Cavada G, Diaz C, Aloia TA, Chun YS, Tzeng CD, Okuno M, Goumard C, Vauthey JN, Lee JE, Conrad C. Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status. J Gastrointest Surg. e-Pub 7/2017. PMID: 28752405. 181. Yamashita S, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN. Hepatic Atrophy Following Preoperative Chemotherapy Predicts Hepatic Insufficiency after Resection of Colorectal Liver Metastases. J Hepatol 67(1):56-64, 7/2017. e-Pub 2/2017. PMID: 28192187. 182. Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MHG. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol 24(7):2031-2039, 7/2017. e-Pub 1/2017. PMID: 28124275. 183. Omichi K, Cloyd JM, Yamashita S, Tzeng, CD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Neutorphil-to-lymphocyte ratio predicts prognosis afer neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. e-Pub 7/2017. 184. Omichi K, Cloyd JM, Yamashita S, Tzeng CD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery. e-Pub 7/2017. PMID: 28688518. 185. Ho V, Short MN, Aloia TA. Can postoperative process of care utilization or complication rates explain the volume-cost relationship for cancer surgery? Surgery 162(2):418-428, 8/2017. e-Pub 4/2017. PMID: 28438333. 186. Chun YS, Passot G, Yamashita S, Nusrat M, Katsonis P, Loree JM, Conrad C, Tzeng CD, Xiao L, Aloia TA, Eng C, Kopetz SE, Lichtarge O, Vauthey JN. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Ann Surg. e-Pub 8/2017. PMID: 28767562. 187. Kim BJ, Day RW, Davis CH, Narula N, Kroll MH, Tzeng CD, Aloia TA. Extended Pharmacologic Thromboprophylaxis in Oncologic Liver Surgery is Safe and Effective. J Thromb Haemost. e-Pub 8/2017. PMID: 28846822. 188. Vinuela E, Vega EA, Yamashita S, Sanhueza M, Mege R, Cavada G, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low- Incidence Countries. Ann Surg Oncol 24(8):2334-2343, 8/2017. e-Pub 4/2017. PMID: 28417239. 189. Cata JP, Velasquez JF, Ramirez MF, Vauthey JN, Gottumukkala V, Conrad C, Kim BJ, Aloia TA. Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol 15(1):152, 8/2017. e-Pub 8/2017. PMID: 28807031. 190. Davis CH, Kao LS, Fleming JB, Aloia TA, Texas Alliance for Surgical Quality Collaborative. Multi-Institution Analysis of Infection Control Practices Identifies the Subset Associated with Thomas A. Aloia, M.D., F.A.C.S. Page 20 of 52 Best Surgical Site Infection Performance: A Texas Alliance for Surgical Quality Collaborative Project. J Am Coll Surg. e-Pub 8/2017. PMID: 28919125. 191. Yamashita S, Venkatesan AM, Mizuno T, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases. JAMA Surg:e172986. e-Pub 8/2017. PMID: 28854316. 192. Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA. Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford) 19(8):706-712, 8/2017. e-Pub 5/2017. PMID: 28528267. 193. Aloia TA, Kim BJ, Segraves-Chun YS, Cata JP, Truty MJ, Shi Q, Holmes A, Soliz JM, Popat KU, Rahlfs TF, Lee JE, Wang XS, Morris JS, Gottumukkala VNR, Vauthey JN. A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia After Major Hepatopancreatobiliary Surgery. Ann Surg 266(3):545-554, 9/2017. PMID: 28746153. 194. Conrad C, Vauthey JN, Masayuki O, Sheth RA, Yamashita S, Passot G, Bailey CE, Zorzi D, Kopetz S, Aloia TA, You YN. Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases. Ann Surg Oncol. e-Pub 9/2017. PMID: 28929463. 195. Omichi K, Mizuno T, Okuno M, Tzeng CD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Long term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol. e-Pub 9/2017. PMID: 28958732. 196. You YN, Shiozaki H, Lee JE, Passot G, Goumard C, Okuno M, Aloia TA, Eng C, Chang G, Vauthey JN, Conrad C. Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection. Ann Surg Oncol 24(9):2595, 9/2017. e-Pub 5/2017. PMID: 28510798. 197. Patel SH, Kim BJ, Tzeng CD, Chun YS, Conrad C, Vauthey JN, Aloia TA. Reduction of cardiopulmonary/renal complications with serum BNP-guided volume status management in post-hepatectomy patients. J Gastrointest Surg. e-Pub 10/2017. PMID: 29234998. 198. Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHG. Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surg 152(11):1048-1056, 11/2017. e-Pub 7/2017. PMCID: PMC5710421. 199. Cloyd JM, Chun YS, Ikoma N, Vauthey JN, Aloia TA, Cuddy A, Rodriguez-Bigas MA, Nancy You Y. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome. J Gastrointest Cancer. e-Pub 12/2017. PMID: 29238914. 200. Yamashita S, Sheth RA, Niekamp AS, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status. Ann Surg 266(6):1045-1054, 12/2017. e-Pub 10/2016. PMID: 27735824. 201. Huang SY, Aloia TA. Portal Vein Embolization: State-of-the-Art Technique and Options to Improve Liver Hypertrophy. Visc Med 33(6):419-425, 12/2017. e-Pub 11/2017. PMCID: PMC5757523. 202. Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology 93(4):233-242, 2017. e-Pub 7/2017. PMID: 28683459. 203. Narula N, Kim BJ, Davis CH, Dewhurst WL, Samp LA, Aloia TA. A proactive outreach intervention that decreases readmission after hepatectomy. Surgery. e-Pub 1/2018. PMID: 29325786. 204. Kim B, Prakash LR, Narula N, Davis CH, Kim M, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CW. Contemporary Analysis of Complications Associated with Biliary Stents during Neoadjuvant Therapy for Panceatic Adenacarcinoma. e-Pub 1/2018. Thomas A. Aloia, M.D., F.A.C.S. Page 21 of 52 205. Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CD, Vauthey JN. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol 44(1):122-129, 1/2018. e-Pub 11/2017. PMCID: PMC5742306. 206. Omichi K, Yamashita S, Cloyd JM, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN, Tzeng CD. Portal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy. J Gastrointest Surg 22(1):60-67, 1/2018. e-Pub 6/2017. PMID: 28585106. 207. Hishaam NI, Cox S, Cooper A, Aloia TA. The Morbidity and Mortality of Hepaticojejunostomies for Complex Bile Duct Injuries: A Multi-instutional Analysis of Risk Factors and Outcomes Using NSQIP. HPB (Oxford). e-Pub 2/2018. 208. Mizuno T, Cloyd JM, Omichi K, Chun YS, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JN. Two-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases. J Am Coll Surg. e-Pub 2/2018. PMID: 29454099. 209. Lunsford KE, Javle M, Heyne K, Shroff RT, Abdel-Wahab R, Gupta N, Mobley CM, Saharia A, Victor DW, Nguyen DT, Graviss EA, Kaseb AO, McFadden RS, Aloia TA, Conrad C, Li XC, Monsour HP, Gaber AO, Vauthey JN, Ghobrial RM, Methodist–MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC). Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol. e-Pub 3/2018. PMID: 29548617. 210. Mizuno T, Cloyd JM, Vicente D, Omichi K, Chun YS, Kopetz SE, Maru D, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JN. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. e-Pub 3/2018. PMID: 29551247. 211. Okuno M, Goumard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Aloia TA, Fleming JB, Lee JE, Vauthey JN, Conrad C. Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc 32(4):1776-1786, 4/2018. e-Pub 9/2017. PMCID: PMC5845466. 212. Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD. Vein Resection during Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Patency Rates and Outcomes Associated with Thrombosis. J Surg Oncol. e-Pub 5/2018. PMID: 29723419. 213. Kim B, Aloia TA. Contemporary Analysis of Complications Associated with Biliary Stents During Neoadjuvant THerapy for Pancreatic Adenocarcinoma. In Press. 214. Katz MH, Fleming JB, Aloia TA, Vauthey JN, Lee JE, Michael K, Parker, NH, Denbo JW. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. Journal of Surgical Oncology. In Press. 215. Odisio BC, Yamashita S, Huang SY, Kopetz SE, Ahrar K, Mizuno T, Conrad C, Aloia TA, Chun YS, Gupta S, Vauthey JN. Impact of prior hepatectomy history on local tumor progression after percutaneous ablation of colorectal liver metastases. Journal of Vascular and Interventional Radiology. In Press. 216. Odisio BC, Richter M, Aloia TA, Conrad C, Ahrar K, Gupta S, Vauthey JN, Huang SY. Use of prophylactic antibiotics to prevent abscess formation following hepatic ablation in patients with prior enterobiliary manipulation. In Press. 217. Aloia TA. Vein Resection during Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Patency Rates and Outcomes Associated with Thrombosis. Journal of Surgical Oncology. In Press. Invited Articles 1. Aloia TA, Adam R, Abdalla EK, Azoulay D, Curley S, Vauthey JN, Castaing D. Evidence for Resection of Colorectal Cancer. Current Colorectal Cancer Reports 2, 1/2006. Thomas A. Aloia, M.D., F.A.C.S. Page 22 of 52 2. Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D. Long-term Results of Hepatic Resection Following, Conversion of Initially Unresectable Colorectal Metastases with Systemic Chemotherapy. Current Colorectal Cancer Reports 2, 1/2006. 3. Adam R, Miller R, Pitombo M, Wicherts DA, de Haas RJ, Bitsakou G, Aloia TA. Two Stage Hepatectomy Approach for Initially Unresectable Colorectal Hepatic Metastases. Surg Oncol Clin N Am 16(3):525-36, viii, 7/2007. PMID: 17606192. 4. Aloia TA, Fahy BN. Chemotherapy-associated liver injury: Does it really matter? Current Colorectal Cancer Reports 5:108-13, 2009. 5. Aloia TA, Fahy BN. Chemotherapy-associated hepatotoxicity: How concerned should we be? Expert Rev Anticancer Ther 10(4):521-27, 4/2010. PMID: 20397917. 6. Andreou A, Aloia TA, Brouquet A, Vauthey JN. Recent advances in the curative treatment of colorectal liver metastases. Gastrointest Cancer Res 4(4 Suppl 1):S2-8, 7/2011. PMCID: PMC3283006. 7. Tzeng CW, Aloia TA. Colorectal Liver Metastases. J Gastrointest Surg 17(1):195-202, 1/2013. e-Pub 10/2012. PMID: 23054896. 8. Cooper AB, Aloia TA. Managing Disappearing Liver Metastases Following Chemotherapy. Current Colorectal Cancer Reports. e-Pub 4/2014. 9. Buell J, Geller D, Asbun H, Aloia TA, Tsung A, Jarnagin W. On the Spot: Developments in Approaches to Liver Resection. General Surgery News 41(09):2-11, 9/2014. 10. Ganai S, Thirunavukarasu P, Aloia TA, Choti MA. Timing of Therapies for Patients with Resectable Hepatic Colorectal Metastases. ASCO Connection, 4/2015. 11. Aloia TA. Insights into ALPPS. Eur J Surg Oncol 41(5):610-1, 5/2015. e-Pub 2/2015. PMID: 25716333. 12. Aloia TA. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy: Portal Vein Embolization Should Remain the Gold Standard. JAMA Surg 150(10):927-8, 10/2015. e-Pub 8/2015. PMID: 26308668. 13. Kim BJ, Aloia TA. Cost-Effectiveness of Palliative Surgery versus Nonsurgical Procedures in Gastrointestinal Cancer Patients. J Surg Oncol 114(3):316-22, 9/2016. e-Pub 5/2016. PMID: 27132654. 14. Aloia TA. Extending the Limits of Resection for Colorectal Liver Metastases: Bilateral Disease. J Gastrointest Surg 21(1):193-195, 1/2017. e-Pub 9/2016. PMID: 27649705. 15. Narula N, Aloia TA. Portal Vein Embolization in Extended Liver Resection. Langenbeck’s, 1/2017. 16. Cloyd JM, Aloia TA. Hammer versus Swiss Army knife: Developing a strategy for the management of bilobar colorectal liver metastases. Surgery 162(1):12-17, 7/2017. e-Pub 1/2017. PMID: 28109616. 17. Manso M, Schmelz J, Aloia T. ERAS-Anticipated outcomes and realistic goals. J Surg Oncol 116(5):570-577, 10/2017. e-Pub 9/2017. PMID: 28873504. 18. Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. e-Pub 4/2018. 19. Aloia, TA. Is PVE vs. ALPPS Debatable? JAMA Surgery. In Press. 20. Newhook TE, Aloia TA. The Southhampton Consensus Guidelines for Laparoscopic Liver Surgery: From Innovation to Implementation. In Press. 21. Aloia TA. What is ‘Enhanced Recovery’. Gastointestinal Surgery. In Press. Editorials 1. Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolfe RA, Crane RH, Evans DB, Pisters PWT. Continuing Medical Education (CME) Featured Article: Impact of prolonged recovery after pancreaticoduodenectomy on delivery of adjuvant therapy to patients with pancreatic adenocarcinoma. J Am Coll Surg 204:522-3, 2007. 2. Aloia TA. Curative therapy for HCC: No one size (modality) fits all. [Editorial to Jarnagin W, Chapman WC, Curley SA, D’Angelica M, Dixon E, Rosen C, et al. Surgical Treatment of Hepatocellular Carcinoma: Expert Consensus Statement]. HPB, 2010. Thomas A. Aloia, M.D., F.A.C.S. Page 23 of 52 3. Aloia TA. Predicting outcome in complex cancer surgery. [Editorial to Al-Rafaie, Waddah, et al. Assessment of ACS NSQIP’s Predictive Ability for Adverse Events after Major Cancer Surgery. Ann Surg Oncol 17:2274-82, 2010]. Ann Sug Oncol 17:2260-61, 2010. 4. Aloia TA, Vauthey JN. Management of colorectal liver metastases: past, present, and future. Updates Surg 63(1):1-3, 3/2011. PMID: 21331669. 5. Aloia TA. Adjuvant Surgery for Breast Cancer Liver Metastases. Commentary on « Liver resection and local ablation of breast cancer liver metastases-A systematic review ». Breast Diseases: A Year Book Quarterly 23(2):169-171, 2012. 6. Aloia TA. Precision Hilar Cholangiocarcinoma Surgery. Ann Surg Oncol. e-Pub 3/2018. PMID: 29520653. 7. Aloia TA. Enhanced Recovery in Breast Reconstructive Surgery: The Start of a Movement in Patient-Centered, Value-Driven Care Commentary on « Enhanced recovery after surgery (ERAS) pathways in autologous breast reconstruction: a systematic review. Breast Diseases: A Year Book Quarterly. In Press. Other Articles N/A Abstracts N/A Book Chapters 1. Aloia TA, Harpole DW. Embryology of the Lung. In: General Thoracic Surgery, 5th. Ed(s) Shields TW, LoCicero J, Ponn RB (eds). Lippincott, Williams, and Wilkins: Philadelphia, 15- 26, 1999. 2. Aloia TA, Harpole DW. Embryology of the Lung. In: General Thoracic Surgery, 6th. Ed(s) Shields Tw, LoCicero J, Poon RB (eds). Lippincott, Williams, and Wilkins, Inc.: Philadelphia, 16-28, 2003. 3. Aloia TA, Gershenwald JE. Management of Early-Stage Cutaneous Melanoma. In: Current Problems in Surgery. Ed(s) Wells SA (ed), 455-534, 2004. 4. Aloia TA, Crane OH, Vauthey JN. Gallbladder Carcinoma. In: Textbook of Hepatology: From Basic Science to Clinical Practice, 3rd. Ed(s) Rodes J, Benhamou JP, Rizzetto M, Reichen J, Blei A (ed), 1575-1582, 2006. 5. Vauthey JN, Pawlik TM, Abdalla EK, Aloia TA. Intrahepatic Bile Duct Cancer Staging. In: AJCC Cancer Staging Manual, 7th, 201-210, 2009. 6. Aloia TA. Non-Colorectal Gastrointestinal Liver Metastases. In: Liver Metastases, 169-178, 2009. 7. Aloia TA, Gaber OA, Ghobrial RM. Liver Transplant for Hepatocellular Carcinoma. In: Hepatocellular Carcinoma, 219-238, 2011. 8. Tzeng CW, Aloia TA. Complications of Liver Surgery Including Hepatic Insufficiency. In: The Handbook of Hepatobiliary and Pancreatic Surgery, 2013. 9. Cooper AB, AloiaTA, Vauthey JN, Curley SA. Controversies in Advanced Disease-Surgical Approcaches for Metastatic Resection. In: Surgical Treatment of Colorectal Liver Mets, 2013. 10. Fuks D, Aloia TA, Gayet B. In: Laparoscoic Management of Hepato-Pancreato-Biliary (HPB) Diseases, 2014. 11. Aloia TA. Indications and Contraindications to laparoscopic liver surgery. In: Laparoscopic Liver, Pancreas, Biliary Surgery: Textbook and Atlas, 2014. 12. Aloia TA. Benign Liver Tumors. In: Clinical Decision Support System on Surgery, 2015. 13. Aloia TA, Day R. Managing Early and Late Postoperative Complications following Gastric Surgery. In: Gastric Cancer Principles and Practice, 2015. 14. Day R and Aloia TA. Preoperative considerations for major hepatectomy. In: Patologia Del Higado, Via Bilar Y Pancreas, Principios y Practica, 2015. 15. Aloia TA, Vauthey JN. Hepatic Metastasis from Colorectal Cancer. In: Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas. 6th Edition Elsevier, 2016. 16. Thirunavukarasu P, Aloia TA. Preoperative assessment and optimization of the future liver remnant. In: Surg Clin North Am. 96, 2. Ed(s) Cho C, 197-205, e-Book 2016. PMID: 27017859. Thomas A. Aloia, M.D., F.A.C.S. Page 24 of 52 17. Shindoh J, Madoff DC, Aloia TA, Vauthey JN. Preoperative Portal Vein Embolization: Technique and Results. In: Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas. 6th Edition Elsevier, 2016. 18. Cloyd JM, Aloia TA. Colorectal Liver Metastases: Patient Selection and Surgical Approach. In: Primary and Metastatic Liver Tumors: Treatment Strategy and Evolving Therapies, 2017. 19. Day RW, Aloia TA. Early Recovery After Surgery pathways for hepatic surgery. In: Optimizing Outcomes for Liver and Pancreas Surgery, 2017. 20. Davis CH, Kim BJ, Aloia TA. Should Hepatectomy be Performed in Octogenarians? In: Hepato-Pancreato-Biliary and Transplant Surgery: Practical Management of Dilemmas, 2017. 21. Narula N, Aloia TA. Trends in Enhanced Recovery. In: SCOPE, 2017. 22. Fuks D, Aloia TA, Gayet B. Enhanced Recovery After HPB Surgery. In: Laparoscopic Liver, Pancreas and Biliary Surgery: Textbook and Illustrated Video Atlas. In Press. 23. Ismael H, Aloia TA. Management of Testicular Cancer Liver Metastases. In: Noncolorectal Non-Neuroendocrine Liver Tumors. Ed(s) Isidora Dicarlo. Springer. In Press. 24. Aloia TA. Minimally Invasive Liver Surgery: Indications and Contraindications. In: Laparoscopic Liver, Pancreas and Biliary Surgery: Textbook and Illustrated Video Atlas. In Press. 25. You YN, Eng C, Aloia TA. Multidisciplinary Management of Stage IV Disease. In: Seminars in Colon and Rectal Surgery: Colon Cancer Issue. In Press. 26. Cloyd J, Aloia TA. Patient Selection and Surgical Approach to Colorectal Cancer Liver Metastases. In: Primary and Metastic Liver Tumors. In Press. Books (edited and written) N/A Letters to the Editor 1. Aloia TA, Vauthey JN. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): What is Gained and What is Lost? Ann Surg 256(3):e9; author reply e16-9, 9/2012. PMID: 22868369. 2. Aloia, TA, Loyer, EL. Fancier and More Expensive Doesn’t Mean Better: An Argument for CT Staging of Patients with Colorectal Liver Metastases. Ann Surg Oncol, 2013. 3. Aloia TA, Vauthey JN. Reply: Air Leak Test, Two Hands Are Better Than None. J Am Coll Surg 218(5):1078-9, 5/2014. PMID: 24745576. 4. Aloia TA, Gottumukkala V. Reply: Transfusion reduction in liver surgery is a team sport. Surgery 160(1):248, 7/2016. e-Pub 2/2016. PMID: 26936522. Manuals, Teaching Aids, Other Teaching Publications 1. Aloia TA. Complications in General Surgery In: Pocket Surgery. Lippincott, Williams and Wilkins, Inc.: Philadelphia, 1/2002. 2. Aloia TA. Surgical Oncology Ultrasound Training Curriculum, The University of Texas MD Anderson Cancer Center, 2013. 3. Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Learning Management System: SAGES University, 1/2014. Other Publications N/A EDITORIAL AND REVIEW ACTIVITIES Editor/Service on Editorial Board(s) Associate Section Editor, Annals of Surgical Oncology, Healthcare Policy and Outcomes Section, 2014-2016 Section Editor, Annals of Surgical Oncology, Hepatobiliary Tumors Section, 2016-present Member of Editorial Review Board Invited Editorial Board Member, Journal of Oncology Practice, 2011-2020 Invited Editorial Board Member, Hepato-Pancreato-Biliary, 2014-present Thomas A. Aloia, M.D., F.A.C.S. Page 25 of 52 Invited Editorial Board Member, Annals of Surgery, Liver Section, 2015 Invited Editorial Board Member, Surgery, 2015-2017 Invited Editorial Board Member, Langenbeck’s Archives of Surgery, 2016-present Journal Reviewer Reviewer, Cancer, 2006-present Reviewer, American Journal of Surgery, 2007-present Reviewer, Annals of Surgery, 2008-present Reviewer, Annals of Surgical Oncology, 2008-present Reviewer, Journal of the American College of Surgeons, 2008-present Reviewer, Transplantation, 2008-present Reviewer, Clinical Colorectal Cancer, 2009-present Reviewer, Journal of Surgical Oncology, 2009-present Reviewer, International Journal of Surgical Oncology, 2010-present Reviewer, Diseases of the Esophagus, 2011-present Reviewer, Hepato-Pancreato-Biliary, 2011-present Reviewer, Surgery, 2011-present Reviewer, The Oncologist, 2012-present Reviewer, World Journal of Surgery, 2012-present Reviewer, Journal of Surgical Research, 2013-present Reviewer, European Journal of Surgical Oncology, 2015-present Reviewer, Journal of Gastroenterology and Hepatology, 2015-present Reviewer, Pediatrics, 2015-present Reviewer, Surgical Endoscopy, 2015-present Reviewer, Applied Clinical Informatics Journal, 2016-present Reviewer, Digestive Surgery, 2016-present Reviewer, Journal of the National Comprehensive Cancer Network, 2016-present Reviewer, Langenbecks Archives of Surgery, 2017-present Other Editorial and Review Activities Abstract Reviewer, Society of Surgery of the Alimentary Tract Annual Meeting, 2008-2010 Abstract Reviewer, American Transplant Congress, 2009-2010 Abstract Reviewer, American College of Surgeons Clinical Congress, 2010-2012 Abstract Reviewer, Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting, 2010-2012 Abstract Reviewer, International Hepato-Pancreato-Biliary Association 10th World Congress, 2012 Abstract Reviewer, AHPBA Annual Meeting, 2013-2015 Abstract Reviewer, International Hepato-Pancreato-Biliary Association 12th World Congress, 2015 Abstract Reviewer, International Hepato-Pancreato-Biliary Association 13th World Congress, 2018-2019 TEACHING Thomas A. Aloia, M.D., F.A.C.S. Page 26 of 52 Teaching Within Current Institution – The University of Texas MD Anderson Cancer Center Formal Teaching Courses Taught Instructor, The University of Texas MD Anderson Cancer Center MINTOS Fellow Training Course 9/2011 Instructor, The University of Texas MD Anderson Cancer Center MINTOS Fellow Training Course 9/2012 Lecturer, The University of Texas MD Anderson Cancer Center Colorectal Cancer, Course Hours: 2 3/2013 Instructor, The University of Texas MD Anderson Cancer Center MINTOS Education and Laboratory Course 8/2013 Director, Surgical Oncology and HPB Abdominal Ultrasound Course, Course Hours: 2 9/2013 Moderator, Total Pancreatectomy/HPB Video Grand Rounds, Course Hours: 1 1/2014 Instructor, The University of Texas MD Anderson Cancer Center MINTOS Education and Laboratory Course 5/2014 Director, Surgical Oncology and HPB Abdominal Ultrasound Course, Course Hours: 2 9/2014 Instructor, Surgical Care and Considerations for potentially resectable metastatic patients, Medical Education Program on CRC – GI Multidisciplinary Cancer Management 11/2014 Director, Surgical Oncology and HPB Abdominal Ultrasound Course, Course Hours: 2 9/2015 Moderator, Non Colorectal Liver Mets/HPB Video Grand Rounds, Course Hours: 1 10/2015 Moderator, AHPBA Teleconference, Course Hours: 2 10/2015 Instructor, Surgical Care and Considerations for potentially resectable metastatic patients, Medical Education Program on CRC – GI Multidisciplinary Cancer Management 11/2015 Director, Surgical Oncology and HPB Abdominal Ultrasound Course, Course Hours: 3 9/2016 Instructor, GME Competency Lecture Series: The Personal Business Medicine, Course Hours: 1 5/2017 Director, Surgical Oncology and HPB Abdominal Ultrasound Course, Course Hours: 3 9/2017 Lecturer, The University of Texas MD Anderson Cancer Center GME Core Curriculum, Course Hours: 1 2017-present Training Programs Fellowship Program Director, HepatoPancreatoBiliary Surgery Fellowship Program Thomas A. Aloia, M.D., F.A.C.S. Page 27 of 52 11/2011-present Fellowship Program Director, International Surgical Oncology Fellowship Program 6/2014-present Other Formal Teaching Lecturer, Faculty Leadership Academy, The Value Equation 101, Course Hours: 2 5/2017 Lecturer, Faculty Leadership Academy, Value Based Cancer Center Module, Course Hours: 2 2017-present Supervisory Teaching Committees Advisory Committees Committee Member, Department of Surgical Oncology Program Evaluation Committee, Surgical Oncology Fellows, 2011-present Supervisory Committees N/A Examining Committees N/A Direct Supervision Undergraduate and Allied Health Students N/A Medical Students Research Mentor, Surgical Oncology, Camille Keenan, MD, 2/2015 Graduate Students N/A Postdoctoral Research Fellows Research Mentor, Ryan W. Day, MD, 7/2014-6/2015 Research Mentor, Bradford J. Kim, MD, 7/2015-6/2017 Research Mentor, Catherine Hambleton Davis, MD, 8/2016-7/2017 Research Mentor, Nisha Narula, MD, 12/2016-6/2017 Research Mentor, Rebecca Marcus, MD, 7/2017-6/2018 Reserach Mentor, Heather Lillemoe, MD, 7/2017-6/2019 Clinical Residents and Fellows Instructor, Daniel Abbott, MD, 11/2010-6/2012 Instructor, John Hyngstrom, MD, 11/2010-6/2012 Instructor, Joshua Hill, MD, 11/2010-6/2012 Instructor, Maria Russell, MD, 11/2010-6/2012 Instructor, Paxton Dickson, MD, 11/2010-6/2012 Instructor, Robert Roses, MD, 11/2010-6/2012 Research Mentor, Amanda Cooper, MD, 7/2011-6/2013 Research Mentor, Ching-Wei D. Tzeng, MD, 7/2011-6/2013 Instructor, Mark J. Truty, MD, 11/2011-6/2012 Instructor, Ryan Michael Thomas, MD, 11/2011-6/2012 Instructor, Genevieve Boland, MD, 11/2011-6/2014 Thomas A. Aloia, M.D., F.A.C.S. Page 28 of 52 Instructor, William Tseng, MD, 11/2011-6/2014 Program Director, The University of Texas MD Anderson Cancer Center AHPBA HPB Fellow, Ching-Wei D. Tzeng, MD, 7/2012-6/2013 Instructor, Christina Roland, MD, 11/2012-6/2014 Insructor, Nader Massarweh, MD, 11/2012-6/2014 Instructor, Natasha Rueth, MD, 11/2012-6/2014 Instructor, Warren Tseng, MD, 11/2012-6/2014 Program Director, The University of Texas MD Anderson Cancer Center AHPBA HPB Fellow, Amanda Cooper, MD, 7/2013-6/2014 Instructor, Callisia Clarke, MD, 7/2013-6/2016 Instructor, Andre Ilbawi, MD, 7/2014-6/2015 Instructor, Chee-Chee Stucky, MD, 7/2014-6/2015 Instructor, Christina Bailey, MD, 7/2014-6/2015 Program Director, The University of Texas MD Anderson Cancer Center AHPBA HPB Fellow, Hishaam Ismael, MD, 7/2014-6/2015 Instructor, Hop Tran Cao, MD, 7/2014-6/2015 Instructor, Joe Spencer Liles, MD, 7/2014-6/2015 Instructor, Michael Kim, MD, 7/2014-6/2015 Instructor, Nicole de Rosa, MD, 7/2014-6/2015 Instructor, Sean Dineen, MD, 7/2014-6/2015 Instructor, Wayne Shannon Orr, MD, 7/2014-6/2015 Instructor, William Burns, MD, 7/2014-6/2015 Instructor, Guy « Travis » Clifton, MD, 7/2014-6/2016 Instructor, Jason Denbo, MD, 7/2014-6/2016 Instructor, Lee Starker, MD, 7/2014-6/2016 Instructor, Victor Phuoc, MD, 7/2014-6/2016 Program Director, The University of Texas MD Anderson Cancer Center Surgical Oncology International Fellow, Aisha Akhtar, MD, 7/2015-6/2016 Program Director, The University of Texas MD Anderson Cancer Center AHPBA HPB Fellow, Pragatheeshwar Thirunavukarasu, MD, 7/2015-6/2016 Program Director, The University of Texas MD Anderson Cancer Center Surgical Oncology International Fellow, Tarik Sammour, MD, 4/2016-3/2017 Instructor, The Univeristy of Texas MD Anderson Cancer Center, Ashley Holder, MD, 7/2016-6/2017 Program Director, The University of Texas MD Anderson Cancer Center AHPBA HPB Fellow, Jason Denbo, MD, 7/2016-6/2017 Instructor, Jordan Cloyd, MD, 7/2016-6/2017 Instructor, Michael Egger, MD, 7/2016-6/2017 Instructor, Peter Prieto, MD, 7/2016-6/2017 Instructor, The Univeristy of Texas MD Anderson Cancer Center, Rebecca Snyder, MD, 7/2016-6/2017 Thomas A. Aloia, M.D., F.A.C.S. Page 29 of 52 Instructor, The University of Texas MD Anderson Cancer, Sameer Patel, MD, 7/2016- 6/2017 Instructor, Travis Grotz, MD, 7/2016-6/2017 Fellow, International Surgery Fellowship, Perparim Limani, MD, PhD, 4/2017-3/2018 Program Director, The University of Texas MD Anderson Cancer Center AHPBA HPB Fellow, Eve Simoneau, MD, 8/2017-7/2018 Other Supervisory Teaching N/A Teaching Outside Current Institution Formal Teaching Courses Taught Instructor, Physician Assistant Program, Duke University 1998-2000 Instructor, Advanced Trauma Life Support, North Carolina 1999-2003 Lecturer, Gastrointestinal Cancers, European University 2005-2006 Instructor, Laparoscopic Liver Resection for Hepatocellular Carcinoma in Cirrhosis, Post Graduate Course, 5th World Congress for Hepatocellular Carcinoma 1/2007 Lecture/Group Leader, Basic Science Clinical Core Competency, The Methodist Hospital General Surgery 7/2007-10/2010 Lecturer, Down-Staging HCC, The Methodist Hospital Hepatology and Liver Transplant Symposium 2/2009 Lecturer, Management of Metastatic Liver Tumors, The Methodist Hospital Hepatology and Liver Transplant Symposium 10/2009 Instructor, Beginning and Advanced Liver Ultrasound Course, ASC 5th Annual Meeting, San Antonio, TX 2/2010 Lecturer, Transaterial Chemo and Radioembolization in Primary and Metastatic Liver Malignancies: Matching the Modality to the Disease?, AHPBA Postgraduate Course 3/2011 Instructor, Instructional HPB Ultrasound and Advanced Technology HPB Fellows’ Course, AHPBA Annual Meeting 2/2014 Instructor, Instructional HPB Ultrasound and Advanced Technology HPB Fellows’ Course, AHPBA Annual Meeting 3/2015 Director, Continuing Medical Education Conference: Gastrointestinal Malignancies Section: HPB Malignances, American College of Surgeons Meeting 10/2016 Instructor, Continuing Medical Education Conference: Gastrointestinal Malignancies Section: HPB Malignancies, American College of Surgeons Meeting 10/2016 Thomas A. Aloia, M.D., F.A.C.S. Page 30 of 52 Instructor, Instructional HPB Ultrasound and Advanced Technology HPB Fellows’ Course, AHPBA Annual Meeting 3/2017 Training Programs N/A Other Formal Teaching N/A Supervisory Teaching Committees Advisory Committees N/A Supervisory Committees N/A Examining Committees N/A Direct Supervision Undergraduate and Allied Health Students N/A Medical Students N/A Graduate Students N/A Postdoctoral Research Fellows N/A Clinical Residents and Fellows N/A Other Supervisory Teaching N/A CONFERENCES AND SYMPOSIA Organization of Conferences/Symposia (Include chairing session) AHPBA Americas North/South Conference, Santiago, Chile, Co-Chair, 6/2011 SSO/SSAT/AHPBA Consensus Conference on the Multidisciplinary Treatment of Colorectal Cancer Liver Metastases, San Francisco, CA, Co-Chair, 1/2012 1st Annual AHPBA Clinical Guideline Symposium on VTE Prophylaxis in Liver Surgery, Miami, FL, Chair, 3/2012 AHPBA Best of Consensus Conference Symposium, Miami, FL, Chair, 3/2012 2nd Annual AHPBA Clinical Guideline Symposium on Epidural Analgesia in Liver and Pancreas Surgery, Miami, FL, Chair, 2/2013 DDW AHPBA/SSAT/AASLD Joint Symposium on The Management of Benign Liver Tumors, Orlando, FL, Co-Chair, 5/2013 SSO/SSAT/AHPBA Consensus Conference on the Multidisciplinary Treatment of Bile Duct Cancer, San Francisco, CA, Co-Chair, 1/2014 3rd Annual AHPBA Clinical Guidelines Symposium on Enhanced Recovery in Liver and Pancreas Surgery, Miami, FL, Chair, 2/2014 AHPBA Annual Meeting, Miami, FL, Co-Chair, 2/2014 Thomas A. Aloia, M.D., F.A.C.S. Page 31 of 52 4th Annual AHPBA Clinical Guidelines Symposium on Goal Directed Fluid Therapy, Miami, FL, Chair, 3/2015 AHPBA Annual Meeting, Miami, FL, Program Chair, 3/2015 Global Academic Programs Annual Meeting, Houston, TX, Moderator, 4/2015 Global Academic Programs Annual Meeting, Hepatobiliary Oncology: Current Controversies and Future Challenges, Houston, TX, Session Chair, 4/2015 SAGES Annual Meeting, Cancer Oral Presentations, Nashville, TN, Organizer and Session Chair, 4/2015 SAGES Annual Meeting, SAGES SMART Program Symposium, Nashville, TN, Organizer and Session Chair, 4/2015 NSQIP 2015 Conference Planning Committee, San Diego, CA, Committee Member, 6/2015 ACS-NSQIP Annual Meeting: Enhanced Recovery: Past, Present, and Future, San Diego, CA, Session Organizer/Chair, 7/2015 ACS-NSQIP Annual Meeting: Setting Up an Enhanced Recovery Program (ERP): Elements, Buy- In, and Conflict Resolution Session, San Diego, CA, Session Organizer/Chair, 7/2015 American College of Surgeons Annual Clinical Congress: HPB2 Abstract Session, Chicago, IL, Moderator, 10/2015 American College of Surgeons NSQIP Annual Conference: Ask the Expert: Enhanced Recovery, San Diego, CA, Panelist, 7/2016 American College of Surgeons NSQIP Annual Conference: Enhanced Recovery: Beyond the Basics, San Diego, CA, Moderator, 7/2016 American College of Surgeons NSQIP Annual Conference: Should ZERO be the Goal?, San Diego, CA, Keynote Speaker, 7/2016 Americas Hepato-Pancteato-Biliary Association Annual Meeting: Management of stage IV pancreatic neuroendocrine tumor, Miami, FL, Panelist, 3/2017 Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting: ER Beyond OR, Houston, TX, Session Organizer, 3/2017 Society of American Gastrointestinal and Endoscopic Surgeons: Enhanced Recovery: Beyond Coloirectal Surgery, Houston, TX, Session Organizer/Chair, 3/2017 Society of American Gastrointestinal and Endoscopic Surgeons: Enhanced Recovery: Beyond Colorectal Surgery, Houston, TX, Session Organizer/Chair, 3/2017 TEXMed: Enhanced perioperative recovery and the future of surgical care, Houston, TX, Session Organizer, 5/2017 MD Anderson Value Based Care Open Forum, Houston, TX, Orgainzer, 2/2018 Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting, Seattle, WA, Keynote Speaker, 3/2018 Presentations at National or International Conferences Invited Influence of high response regimens on indications for resection of liver metastasis of colorectal cancer, 2nd Winter Oncology Symposium on Thoracic and Digestive Oncology, Ghent, Belgium, 2006 Decision Analysis Modeling for the Treatment of Patients with Hepatocellular Carcinoma, European University Dilploma, Paul Brousse Hospital, Villejuif, France, 1/18/2006 Impact of Preoperative Systemic Chemotherapy on Liver Histology and on Outcome following Hepatic Resection of Colorectal Cancer Liver Metastases, European University Diploma, Paul Brousse Hospital, Villejuif, France, 3/15/2006 Thomas A. Aloia, M.D., F.A.C.S. Page 32 of 52 Neoadyuvancia En Metastasis Irresecables, XIV Curso de Avances en Cirugia Digestiva, Pamolona, Spain, 5/12/2006 Reseccion En Dos Teimpos, XIV Curso de Avances en Cirugia Digestiva, Pamplona, Spain, 5/12/2006 Liver Resection after Neoadjuvant Therapy, One Day on New Developments in Liver Surgery, Amsterdam, Netherlands, 6/15/2006 Syndrome of Imminent Demise, ACS Clinical Congress Surgical Palliative Care Symposium, Washington, DC, 10/5/2010 Hepatocellular Carcinoma, Setting the Stage: RSNA Refresher Course, RSNA 96th Scientific Assembly and Annual Meeting, Chicago, IL, 11/2010 Does the Aviation Analogy Work in the Operating Room?, SAGES Annual Meeting, San Antonio, TX, 4/2/2011 HCC-bridging techniques: TACE vs RFA or combination, ANZ Royal College of Surgeons Annual Meeting, Adelaide, Australia, 5/4/2011 Liver Transplant for Recipients Over Age 60: A Novel Scoring System Predicts Survival, ANZ Royal College of Surgeons Annual Meeting, Adelaide, Australia, 5/5/2011 Liver Transplantation for Cholangiocarcinoma: Lessons Learned and Future Directions, AHPBA Americas Postgraduate Course, Santiago, Chile, 6/30/2011 Surgical Therapy for Metastatic Colorectal Cancer: When to Refer and To Whom?, MD Anderson Physicians Network Symposium, Houston, TX, 8/2/2011 A Chance to Cut is a Chance to Cure, and Everything Else is Just Palliative, 97th Annual American College of Surgeons Clinical Congress, San Francisco, CA, 10/26/2011 Debate: What is the Best order of Chemotherapy for CRM? – Before Resection, AHPBA 12th Annual Congress, Miami, FL, 3/10/2012 Multidisciplinary Treatment of Colorectal Liver Metastases, SSAT Annual Meeting, San Diego, CA, 5/19/2012 Portocaval Shunt to Facilitate Curative Hepatectomy in a Patient with Severe Liver Chemotoxicity, Centre Hepato-Biliaire/Paul Brousse Hospital Clinical Cases Symposium, Villejuif, France, 6/30/2012 How to Select the Journal Best Adapted to Your Paper, 10th IHPBA World Congress, Paris, France, 7/4/2012 Synchronous Colorectal Liver Metastases: Simultaneous or Staged Surgery, 10th IHPBA World Congress, Paris, France, 7/4/2012 Building Your Practice, 10th IHPBA World Congress, Paris, France, 7/5/2012 Surgical Management of Hepatobiliary Malignancies, 2012 APAO Conference, Scottsdale, AZ, 10/12/2012 Resection and Transplant for HCC, Society of Interventional Radiology (SIR), New Orleans, LA, 4/13/2013 Surgery for mCRC – Current Evidence: How can IO Help?, Society of Interventional Radiology (SIR), New Orleans, LA, 4/13/2013 Comparação da RMN com a TAC na avaliação pré-operatória da toxicidade da quimioterapia, Jornadas Internacionais de Cirurgia International Surgical Meeting, Coimbra, Portugal, 4/20/2013 Embolização portal: eficácia na estimulação da regeneração hepato-celular em doentes com pequeno fígado remanescente (LW/BW<0,5%) e como factor preditivo de morbilidade, Jornadas Internacionais de Cirurgia International Surgical Meeting, Coimbra, Portugal, 4/20/2013 Thomas A. Aloia, M.D., F.A.C.S. Page 33 of 52 Prevenção das fístulas biliares em cirurgia hepato-biliar, Jornadas Internacionais de Cirurgia International Surgical Meeting, Coimbra, Portugal, 4/20/2013 Morbidity and Mortality After Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification, SSAT 54th Annual Meeting, Orlando, FL, 5/20/2013 Preoperative Portal Vein Embolization, SSAT 54th Annual Meeting, Orlando, FL, 5/20/2013 Conventional two stage procedure vs ALPPS debate, E-AHPBA Annual Meeting Belgrade, Belgrade, Yugoslavia, 5/31/2013 New Understandings of venous thromboembolism after liver surgery, E-AHPBA Annual Meeting Belgrade, Belgrade, Yugoslavia, 5/31/2013 The Airleak test: A new strategy to prevent post-hepatectomy bile leak, E-AHPBA Annual Meeting Belgrade, Belgrade, Yugoslavia, 5/31/2013 Hilar Cholangiocarcinoma: Indications for Resection and Transplant, Mexican HPB Association, Cancun, Mexico, 7/4/2013 Neuroendocrine Tumors of the Liver, Mexican HPB Association, Cancun, Mexico, 7/5/2013 Clinical Liver Surgery, ACS NSQIP, Targeted Procedure and Disease, Breakout Session, San Diego, CA, 7/15/2013 The Role of NSQIP in Quality Improvement, UT Clinical Safety and Effectiveness Conference, San Antonio, TX, 9/27/2013 Surgery for HCC: resection and transplantation, HPBASA Congress, Capetown, South Africa, 10/11/2013 Surgery for CRC metastases, HPBASA Congress, Capetown, South Africa, 10/12/2013 Dilemmas in surgery for hilar cholangiocaracinoma, HPBASA Congress, Capetown, South Africa, 10/13/2013 Is Perfection the Goal in HPB surgery, COSA’s 40th Annual Scientific Meeting, Sydney, Australia, 11/10/2013 Safety & Quality in Cancer Care, COSA’s 40th Annual Scientific Meeting, Sydney, Australia, 11/12/2013 Two-surgeon Technique for Hepatic Parenchymal Transection, COSA’s 40th Annual Scientific Meeting, Sydney, Australia, 11/12/2013 The Potential for Freedom from adjuvant chemotherapy: An underrecognized benefit of surgical therapy for colorectal liver metastases, COSA’s 40th Annual Scientific Meeting, Sydney, Australia, 11/13/2013 Multimodality Evaluation of Patients with Hilar Cholangiocarcinoma, AHPBA Consensus Conference on Multidisciplinary Care of Patients wiht Bile Duct Cancer, San Francisco, CA, 1/15/2014 Surgical Care & Considerations for potentially resectable metastatic patients, Medical Education Program on Gastrointestinal Cancer Management, Houston, TX, 1/24/2014 Enhanced Recovery in Liver Surgery, AHPBA Annual Meeting, Miami, FL, 2/19/2014 Liver Parenchymal Transection: Cirrhotic and Non-Cirrhotic, SAGES Annual Meeting, Salt Lake City, UT, 4/3/2014 Developing New Strategies for Managing Escape Lesions, Southwest Oncology Group, A National Clinical Research Group, San Francisco, CA, 5/2/2014 Prevention and Treatment of Postsurgical Bile Leaks, SSAT/DDW Annual Meeting, DDW, Chicago, IL, 5/5/2014 Thomas A. Aloia, M.D., F.A.C.S. Page 34 of 52 Highlight of the Consensus Conference on the Multidiscplinary Treatment of Bile Duct Cancer, Simpósio Internacional de Câncer de Fígado Pâncreas e Vias Biliares DA CB-IHPBA, São Paulo, Brazil, 8/22/2014 Neoadjuvant treatment in pancreatic cancer. When and how to perform it, Simpósio Internacional de Câncer de Fígado Pâncreas e Vias Biliares DA CB-IHPBA, São Paulo, Brazil, 8/22/2014 Neuroendocrine liver metastases – therapeutics updates in 2014, Simpósio Internacional de Câncer de Fígado Pâncreas e Vias Biliares DA CB-IHPBA, São Paulo, Brazil, 8/23/2014 Multidisciplinary Cancer Care Planning, 41° Congreso Argentino de Anestesiología, Buenos Aires, Argentina, 8/28/2014 ALPPS vs. PVE, First ALPPS World Consensus Conference, Hamburg, Germany, 2/28/2015 4th Guidelines Symposium on Goal Directed Fluid Therapy in HPB Surgery, Americas Hepatopancreatobiliary Surgery Association Annual Meeting, Miami, FL, 3/25/2015 Post Graduate Course: Liver Case Panelist, Americas Hepatopancreatobiliary Surgery Association Annual Meeting, Miami, FL, 3/25/2015 Extending the Role of Liver Resection for Extensive CR Metastases: PVE versus AlPPS. What is the Reality?, Society of Surgical Oncology Annual Meeting, Houston, TX, 3/26/2015 Overview: Costs of Perioperative Cancer Care, Society of Surgical Oncology Annual Meeting, Houston, TX, 3/26/2015 Enhanced Recovery after Cancer Surgery, Global Academic Programs Annual Meeting, Houston, TX, 4/14/2015 Hepatobiliary Interactive Case Presentations with Expert Panel, Global Academic Programs Annual Meeting, Houston, TX, 4/15/2015 MDA report on ER in Liver Surgery, Global Academic Programs Annual Meeting, Houston, TX, 4/16/2015 Enhanced Recovery Programs For MIS Surgery, SAGES SMART Program Symposium, SAGES Annual Meeting, Nashville, TN, 4/17/2015 Hurdles to Establishing an ERP: The Surgeon’s Perspective, ASC-NSQIP Annual Meeting, San Diego, CA, 7/25/2015 Measuring the Value of Enhanced Recovery with Patient Reported Outcomes, ACS-NSQIP Annual Meeting, San Diego, CA, 7/27/2015 The S.T.O.P. UTI Program for Postoperative UTI Reduction, ACS-NSQIP Annual Meeting, San Diego, CA, 7/28/2015 Recent Advances in Multidisciplinary Care of the Gallbladder Cancer Patient, 5th Annual Updates and Breakthroughs in Hematology and Oncology (AUBHO) Conference, Bangkok, Thailand, 8/2015 Organization of a multidisciplinary clinical care pathway in oncology care of the surgical patient, 42nd Argentine Congress of Anesthesiology, Buenos Aires, Argentina, 10/3/2015 Enhanced Recovery for Major Cancer Surgery, American College of Surgeons Annual Clinical Congress, Chicago, IL, 10/5/2015 ER in Upper GI Oncological and Surgery-Is There a Role to Improve Oncological Outcomes, American Society of Anesthesiologists Annual Meeting, San Diego, CA, 10/26/2015 Predictors of Safety and Efficacy of Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases, Western Surgical Association Annual Meeting, Napa Valley, CA, 11/9/2015 Implementation of ERAS: Which Data Should I Collect?, SAGES/ERAS Society Canada, ERAS 2015 Meeting, Montreal, Québec, Canada, 11/14/2015 Thomas A. Aloia, M.D., F.A.C.S. Page 35 of 52 Enhanced Recovery: Goals, Strategies, and Tactics, The University of Texas MD Anderson Cancer Center, 14th Oncology Update: Advances and Controversies, Steamboat Springs, CO, 1/18/2016 Impacto da fast track surgery na cirurgia oncológica do fígado, Annual Meeting of the Sociedad Portuguesa de Cirurgia, Figurera de Foz, Portugal, 3/4/2016 Segurança e qualidade em Cirurgia: novos conceitos e avanços, Annual Meeting of the Sociedad Portuguesa de Cirurgia, Figurera de Foz, Portugal, 3/5/2016 Influencing Your Team Through Effective Communication, American College of Surgeons NSQIP Annual Conference, San Diego, CA, 7/2016 Enhanced Surgical Recovery: A Model for Value-Based Care, Value Based Care Conference, Dallas, TX, 9/21/2016 Hepatobiliary, American College of Surgeons, Washington, DC, 10/17/2016 Malignant Abdomen, American College of Surgeons, Washington, DC, 10/17/2016 What is Enhanced Recovery and How Can I Do It?, SSAT GI Surgery Winter Course, Miami, FL, 12/3/2016 ERAS in liver surgery, Eastern and Western Association of Liver Tumors, Sendai, Japan, 1/2017 If you want to know the best anesthetic plan for liver surgery, just ask the patient: Comparative assessment of 174 patient-reported outcomes, European-African Hepato-Pancreato-Biliary Association 12th Biennial Meeting, Germany, 2017 Multi-institution Analysis of Infection Control Practices Identifies the Subset Associated with Best Surgical Site Infection Performance, The John F., Jr. & Carolyn Bookout Surgical Research Symposium, 2017 Improving Perioperative Outcomes in Cancer Patients, The University of Texas MD Anderson Cancer Center, 15th Oncology Update: Advances and Controversies, Steamboat Springs, CO, 1/13/2017 CRLM: Single Approach or Swiss Army Knife?, Symposium on Hepatopancreaticobiliary Oncology at Whistler, Vancouver, British Columbia, Canada, 2/3/2017 Management of large or centrally located CRLM, Symposium on Hepatopancreaticobiliary Oncology at Whistler, Vancouver, British Columbia, Canada, 2/3/2017 Surgical Considerations: PVE vs. ALPPS, Symposium on Hepatopancreaticobiliary Oncology at Whistler, Vancouver, British Columbia, Canada, 2/3/2017 Surgical outcomes in down-sizing for HCC and mCRC, Symposium on Hepatopancreaticobiliary Oncology at Whistler, Vancouver, British Columbia, Canada, 2/4/2017 ACS NSQIP Benefits: The Improvement beyond Surgical Care, ACS NSQIP_Surgeon Champion Call, Houston, TX, 2/16/2017 I’m stuck: Common problems and solutions from the SMART ERAS FAQs, Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting, Houston, TX, 3/2017 Trials in Progress: Randomized, controlled trial of thoracic epidural analgesia versus intravenous patient controlled analgesia in patients undergoing liver and pancreas resection, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 In Service: NSQIP Data for Managed Care, The University of Texas MD Anderson Cancer Center, 3/3/2017 Debate: Pharmacologic Perioperative VTE Prophylaxis for HPB Surgery is Safe and Standard of Care, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/30/2017 Thomas A. Aloia, M.D., F.A.C.S. Page 36 of 52 Randomized, controlled trial of thoracic epidural analgesia versus intravenous patient controlled analgesia in patients undergoing liver and pancreas resection, American Surgical Association Annual Meeting, Phildelphia, PA, 4/2017 Does Liver hypertrophy equal function?: PVE and ALPPS, Leaping Forward Oncology International Clinical Congress, Lisbon, Portugal, 5/2017 ERAS: A novel approach, Leaping Forward Oncology International Clinical Congress, Lisbon, Portugal, 5/2017 Percutaneous accessory bilioenteric neoanastomosis creation aided by the use of cone-beam computed tomography, Cardiovascular and Interventional Radiological Society of Europe, Houston, TX, 5/2017 Value-Based and Patient-Centric Surgical Care: What Does this Mean?, Enhanced Perioperative Recovery CME Program, Dallas, TX, 5/5/2017 Standards in Reporting and Quality Control Metrics: A Key to Success, Enhanced Perioperative Recovery CME Program, Dallas, TX, 5/6/2017 A different implementation experience, International Clinical Congress, Leaping Forward, Lisbon, Portugal, 5/9/2017 PVE/ALLPS: Volume = Function? Functional liver remnant assessment, International Clinical Congress, Leaping Forward, Lisbon, Portugal, 5/9/2017 Results of 400 hepatectomies treated with an Enhanced Recovery Protocol, International Symposium on Innovative Expert Hepatobiliary Surgery, Dublin, Ireland, 6/2/2017 Avoiding leaks and improving hepatectomy outcomes, American College of Surgeons Quality and Safety Conference, New York, NY, 7/22/2017 Communication about quality issues in a program, American College of Surgeons Quality and Safety Conference, New York, NY, 7/23/2017 The Business of Medicine: How to Start Your Practice, 6th Annual AHPBA Fellows Couse, Charlotte, NC, 8/21/2017 Enhanced Recovery in Hepatobiliary Surgery, American College of Surgeons Clinical Congress, San Diego, CA, 10/24/2017 Utilization of an Enhanced Perioperative Recovery Program Improves Patent Outcomes and reduces opioid use, American College of Surgeons Clinical Congress, San Diego, CA, 10/26/2017 Two Surgeon Technique, The University of Texas MD Anderson Cancer Center, Advanced Hepato-Pancreato-Biliary Surgery, Houston, TX, 11/10/2017 Creating the Team: Finding the Key Motivating Personnel, ERAS USA: 1st Annual Meeting, Dallas, TX, 11/11/2017 How do we collaborate and move the agenda forward, 5th Global conference on Perioperative Care of the Cancer Patient, Houston, TX, 11/29/2017 Improving oncological outcomes in the surgical patient: Translation to bedside, 5th Global Conference on Perioperative Care of the Cancer Patient, Houston, TX, 11/30/2017 Organization of multidisciplinary oncology care of the surgical patient, 5th Global Conference on Perioperative Care of the Cancer Patient, Houston, TX, 11/30/2017 Perioperative strategies to improve oncological outcomes: Role of RIOT, 5th Global Conference on Perioperative Care of the Cancer Patient, Housto, TX, 11/30/2017 Advances in the surgical management of cholangiocarcinoma/transplant, 2nd Annual Sawyer International Pancreatobiliary Symposium, Houston, TX, 12/2/2017 Thomas A. Aloia, M.D., F.A.C.S. Page 37 of 52 Patient Reported Outcomes: How Is This Information Used?, The University of Texas MD Anderson Cancer Center, 16th Oncology Update: Advances and Controversies, Steamboat Springs, CO, 1/12/2018 Reducing the Use of Opiates: A double-edged sword for the cancer patient, The University of Texas MD Anderson Cancer Center, 16th Oncology Update: Advances and Controversies, Steamboat Springs, CO, 1/12/2018 The role of ERAS in value-based helathcare, Enhanced Recovery in Cancer Surgery Symposium, Houston, TX, 2/12/2018 Emerging models that transition payment from volume to value, Women in Surgery Symposium, Clearwater Beach, FL, 2/17/2018 Quality outcomes through teamwork: ERAS, Women in Surgery Symposium, Clearwater Beach, FL, 2/17/2018 Averting Biliary Leaks, Americas Hepato-Pancreato-Biliary Association, Miami, FL, 3/8/2018 Best Practices for Securing a Job and Transitioning into Practice, Americas Hepato- Pancreato-Biliary Association, Miami, FL, 3/8/2018 Relationship Between Enhanced Recovery and Value Based Healthcare, Americas Hepato- Pancreato-Biliary Association, Miami, FL, 3/9/2018 Hilar cholangiocarcinoma: The surgeon’s perspective, The University of Texas MD Anderson Cancer Center, Chicago, IL, 3/22/2018 Managing the future liver remnant: Size and function, Society of Surgical Oncology Annual Meeting, Chicago, IL, 3/22/2018 Meet the professor: The impact of enhanced recoery on oncologic outomes, Society of Surgical Oncology Annual Meeting, Chicago, IL, 3/22/2018 Value-based surgical oncology care: The Value Equation, Society of Surgical Oncology Annual Meeting, 3/22/2018 Intrahepatic cholangiocarcinoma: The surgeon’s perspective, The Univesity of Texas MD Anderson Cancer Center Inter Other, Including Scientific Exhibitions Candida in Pancreatic Infection: A Clinical Experience, Southern California American College of Surgeons Annual Meeting, 1/1994 Molecular markers of treatment resistance or sensitivity in esophageal cancer patients, 35th Annual American Society of Clinical Oncology Meeting, 1999 Positron emission tomography SUR score correlates with the presence of glucose transporters in non-small cell lung tumors, 35th Annual American Society of Clinical Oncology Meeting, 1999 Molecular biologic markers predict the development of cerebral metastases in patients with stage I non-small lung cancer, 85th Annual American College of Surgeons Clinical Congress, 10/1999 Expression of angiogenesis is elevated in cerebral metastases from non-small cell lung cancer, 53rd Annual Society of Surgical Oncology Meeting, 3/2000 Bone marrow CK19 rt-pcr correlates with T-status in patients with lung cancer, 86th Annual American College of Surgeons Clinical Congress, 10/2000 CK19 is superior to MUCI as a marker of micrometastases in patients with non-small cell lung cancer, 86th Annual American College of Surgeons Clinical Congress, 10/2000 Tumor marker expression is predictive of survival in patients with esophageal cancer, 47th Annual Southern Thoracic Surgical Society Meeting, 11/2000 Thomas A. Aloia, M.D., F.A.C.S. Page 38 of 52 Prognostic significance of tumor response following HILP for malignant melanoma, 55th Annual Society of Surgical Oncology Meeting, 2002 Utility of radiographic evaluation for patients with stage III melanoma diagnosed by possible sentinel lymphadenectomy, 4th International Sentinel Node Congress, 1/2004 Impact of prolonged recovery after pancreaticoduodenectomy on delivery of adjuvant therapy to patients with pancreatic adenocarcinoma, 58th Annual Society of Surgical Oncology Meeting, 2005 Solitary colorectal liver metastasis: Resection determines outcome, 113th Scientific Session of the Western Surgical Association, 11/2005 Impact of preoperative systemic chemotherapy on liver histology and on outcome following hepatic resection of colorectal cancer liver metastases, 1st Congress de Chirurgie Digestive et Hepatobiliaire, 12/2005 Can we justify liver resection for patients with hepatic metastases from breast cancer?, 13th Annual European Surgical Association Meeting, 2006 High resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma, 58th Annual Meeting of the Southwestern Surgical Congress, 2006 LiverMetSurvey: Analysis of clinicopathologic factors associated with the efficacy of perioperative chemotherapy in 2,122 patients with colorectal liver metastases, 42nd Annual Meeting of the American Society of Clinical Oncology, 2006 Resection of hepatic colorectal metastasis involving the caudate lobe: perioperative outcome and survival, 6th Annual Meeting of the American Hepato-Pancreato-Biliary Association, 2006 A decision analysis model determines the utility of transarterial chemoembolization (TACE) for cirrhotic patients with HCC awaiting liver transplantation, 7th World Congress of the International Hepato-Pancreato-Biliary Association, 9/2006 A decision analysis model predicts the optimal treatment pathway for colorectal cancer patients with resectable synchronous liver metastases, 60th Annual Cancer Symposium of the Society of Surgical Oncology, 2007 Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005, 7th American Hepato-Pancreato-Biliary Association Meeting, 4/2007 The United States experience with liver transplantation for cholangiocarcinoma: an 18-year review, 7th American Hepato-Pancreato-Biliary Association Meeting, 4/2007 Analysis of outcomes for 231 liver transplants for cystic fibrosis, 7th American Transplant Congress, 5/2007 Analysis of the UNOS OLT experience for recipients over age 60 identifies multiple MELDIndependent prognostic factors, 7th American Transplant Congress, 5/2007 Complete pathological response after preoperative chemotherapy for colorectal liver metastases: predictive factors and long-term survival, Gastrointestinal Cancers Symposium, 2008 Institutional outcomes analysis of ACS-NSQIP data for the development of continuous quality improvement initiatives, American College of Surgeons-National Surgical Quality Improvement Program Annual Meeting, 6/2008 Optimizing Outcome Measurement in Pancreatic Surgery: Can NSQIP Measure Up?, American College of Surgeons-National Surgical Quality Improvement Program Annual Meeting, 6/2008 Ockham’s razor and the chameleon: a cerebellar mass, headache and hypertension. Is it a pheochromocytoma?, 2nd International Symposium on Pheochromocytoma, Cambridge, United Kingdom, 9/2008 Thomas A. Aloia, M.D., F.A.C.S. Page 39 of 52 A Novel Psychosocial Risk Model Identifies Patients At-Risk for Poor Post-Transplant Outcomes, American Transplant Congress, 2009 Analysis of Right Hepatectomies in the NSQIP Database Determines Benchmark Morbidity and Morbidity Rates for Living Related Liver Transplant Donors, American Transplant Congress, 2009 Approach to Liver Tumor Radiofrequency Ablation Impacts Postoperative Complications, Society of Surgical Oncology, 2009 Left versus Right liver Grafts for Living Liver Donation Outcomes Analysis of 544 Hepatectomies in the NSQIP Dataset, American Transplant Congress, 2009 Sequential TACE and RFA improves post liver transplant outcomes in patients with HCC, American Transplant Congress, 2009 Chemotherapy within 30 Days Prior to Liver Resection Does Not Increase Postoperative Morbidity or Mortality, Americas Hepatopancreatobiliary Surgery Association Annual Meeting, 3/2009 Predicting Poor Outcomes Following Hepatectomy: Analysis of 2,313 Hepatectomies in the NSQIP Database, Americas Hepatopancreatobiliary Surgery Association Annual Meeting, 3/2009 A Novel MELD-Based Fungal Prophylaxis Scheme Improves Liver Transplant Nearly Eliminating Postoperative Fungal Infections, American Transplant Congress, 2010 MELD Does Not Predict Futility of Liver Transplantation, International Liver Transplantation Society, 2010 Survival Analysis of Simultaneous Liver/Kidney vs. Liver Transplantation, American Transplant Congress, 2010 A Novel MELD-Based Fungal Prophylaxis Scheme Improves Liver Transplant Survivals by Nearly Eliminating Postoperative Fungal Infections, 2010 International Liver Transplantation Society Meeting, Hong Kong, China, 6/2010 Predictors of Mortality and Major Morbidity Following Surgical Repair of Umbilical Hernias in 170 Patients with Cirrhosis and Portal Hypertension, 2010 International Liver Transplantation Society Meeting, Hong Kong, China, 6/2010 Change in Glomerular Filtration Rate (GFT) as a Predictor of Surgical Outcomes, American College of Surgeons National Surgery Quality Improvement Program (NSQIP) Meeting, 10/2010 Predictors of Mortality and Major Morbidity Following Surgical Repair of Umbilical Hernias in 323 Patients with Cirrhosis and Portal Hypertension, American College of Surgeons Clinical Congress, 10/2010 Careful Selection of HCC Patients for Liver Resection After TACE and PVE Maximizes Longterm Survivals in both Operative and Non-Operative Groups, 7th International Meeting, Hepatocellular Carcinoma: Eastern and Western Experiences, Paris, France, 1/2011 Economic Comparison of Simultaneous and Staged Resection for Synchronous Metastatic Colorectal Cancer, 97th Annual American College of Surgeons Clinical Congress, San Francisco, CA, 10/2011 Hepatic Metastatic Disease Features Predict Outcome after Resection of Liver and Regional Lymph Node Metastases from Colorectal Cancer, 97th Annual American College of Surgeons Clinical Congress, 10/2011 R0 Resection Remains a Primary Goal of Surgery for Colorectal Liver Metastases in the Era of Modern Chemotherapy: Prospective Evaluation in 523 Patients, 97th Annual American College of Surgeons Clinical Congress, 10/2011 Thomas A. Aloia, M.D., F.A.C.S. Page 40 of 52 Risk of Venous Thromboembolism Outweighs Post-Hepatectomy Bleeding Complications: Analysis of 5,651 NSQIP Patients, Americas Hepato-Pancreato-Biliary Association Annual Meeting, 3/9/2012 An Evidence-Based Proposal of Oncology-Specific Risk Factors for Morbidity and Mortality After Complex Cancer Surgery, Society of Surgical Oncology Annual Meeting, 3/24/2012 Greater Complexity of Liver Surgery Is Not Associated With An Increased Incidence of Liver Related Complications Except for Bile Leak: an Experience With 2,628 Consecutive Resections, Society for Surgery of the Alimentary Tract Annual Meeting, San Diego, CA, 5/19/2012 Long-Term Outcomes After Portal Vein Embolization and Major Hepatectomy in Patients with Extensive Neuroendocrine Liver Metastases, 10th International Hepato-Pancreato Biliary Association World Congress, Paris, France, 7/4/2012 The Impact of Postoperative Complications on Outcomes for Patients with Cancer Treated with Palliative Surgery, 16th Annual Interdisciplinary Conference on Supportive Care, Hospice and Palliative Medicine, Houston, TX, 9/8/2012 The Optimal Surgical Strategy for Extensive Liver Malignancy and Very Low Future Liver Remnant Volume: ALLPS vs. Percutaneous Portal Vein Embolization, Western Surgical Association Annual Meeting, Colorado Springs, CO, 11/6/2012 Strengths and Limitations of Extravascular and Liver Specific Contrast Agents in the Evaluation of Liver Lesions, Radiological Society of North America_98th Scientific Assembly & Annual Meeting, Chicago, IL, 11/25/2012 Postoperative Coagulation Abnormalities after Hepatic Resection in Patients Receiving Epidural Analgesia, International Anesthesia Research Society (IARS), 12/2012 Identification of unique somatic mutations with functional relevance through genetic characterization of gallbladder cancer (GB ca), Gastrointestinal American Society of Clinical Oncology, San Francisco, CA, 1/2013 8-Minute Suture Skills Test Predicts Clinical Technical Performance In Advanced Trainee, Academic Surgical Congress, New Orleans, LA, 2/5/2013 Morbidity and Mortality of Pancreaticoduodenectomy After Preoperative Radiation Therapy: A NSQIP Analysis, Society of Surgical Oncology, Orlando, FL, 3/6/2013 Return to Intended Oncologic Treatment (RIOT): A Novel Metric for Evaluating the Efficacy of Open and Minimally Invasive Surgical Oncology, Society of Surgical Oncology, Orlando, FL, 3/6/2013 Surgical Placement of Biological Mesh Spacers to Displace Bowel from Unresectable Liver Tumors Facilitates Safe Delivery of Dose-Intense Radiation Therapy, Society of Surgical Oncology, Orlando, FL, 3/6/2013 Mortality Prediction based on Preoperative Variables for Brain Tumor Resection: Derived from ACS NSQIP Data, Scientific Program Committee of the American Association of Neurological Surgeons, New Orleans, LA, 4/13/2013 Does Laparoscopic Adrenalectomy Jeopardize Oncologic Outcomes for Patients with Adrenocortical Carcinoma?, Society American Gastrointestinal Endoscopic Surgeons Annual Meeting, Baltimore, MD, 4/23/2013 Pelvic Multivisceral Resection for Colorectal Cancer: A Multi-Institutional Analysis of Risk Factors and 30-Day Outcomes, American Society of Colon and Rectal Surgeons Annual Meeting, Phoenix, AZ, 4/28/2013 Effect of postoperative epidural bolus concentration on pain control and fluid requirements after hepatic resection, International Anesthesia Research Society (IARS), San Diego, CA, 5/5/2013 Thomas A. Aloia, M.D., F.A.C.S. Page 41 of 52 Hepatectomy for Liver Metastases from Gastric and Esophageal Cancer: Tumor Biology and Surgical Results Define Outcome, Society for Surgery of the Alimentary Tract_54th Annual Meeting, Orlando, FL, 5/19/2013 Safety and Efficacy of Portal Vein Embolization Before Planned Major Hepatectomy: An Institutional Experience of 358 Patients, Society for Surgery of the Alimentary Tract_54th Annual Meeting, Orlando, FL, 5/19/2013 Atypical Imaging Presentations of Focal Nodular Hyperplasia with Radiologic Pathologic Correlation, Radiological Society of North America (RSNA), Oakbrook, IL, 7/1/2013 The Value of Cancer-Specific Variables in ACS NSQIP Risk Models, American College of Surgeons-National Surgical Quality Improvement Program Annual Meeting, San Diego, CA, 7/14/2013 Using the ACS NSQIP Platform to Create a Specialty-Specific Quality Assessment Database for Oncoplastic Head and Neck Surgery, American College of Surgeons-National Surgical Quality Improvement Program Annual Meeting, San Diego, CA, 7/14/2013 Utilization of Institutional ACS NSQIP Data for Surgeon OPPE and Quality Measurement, ACS NSQIP Annual Meeting, American College of Surgeons-National Surgical Quality Improvement Program Annual Meeting, San Diego, CA, 7/15/2013 Next generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA), Gastrointestinal American Society of Clinical Oncology, Alexandria, VA, 9/2013 Assessing NSQIP Data Based on Surgical Indication: A Novel Way to Identify High Risk Cases, Annual American College of Surgeons Clinical Congress, Washington, DC, 10/2013 Reoperative Surgery: A Critical Risk Factor for Complications inadequately Captured by Operative Reporting and Coping of ‘Lysis of Adhesions’, Western Surgical Association, Salt Lake CIty, UT, 11/5/2013 Borderline Operability in Hepatectomy Patients Is Associated with Higher Rates of Failure to Rescue after Severe Complications, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, FL, 2/21/2014 Central Pancreatectomy and Distal Pancreatectomy for Pancreatic Neck Lesions Result in Equipvalent Long-term Pancreatic Function and Fistula Formation, Society of Surgical Oncology Annual Meeting, Phoenix, AZ, 3/2014 Sarcopenia in Preoperative Therapy for Resectable Pancreatic Cancer: Does It Matter?, Society of Surgical Oncology Annual Meeting, Phoenix, AZ, 3/2014 Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates, The Society for Surgery of the Alimentary Tract, Chicago, IL, 5/2014 Volume Regeneration of Segment 2+3 After Right Portal Vein Embolization in Patients Undergoing 2-Stage Hepatectomy, The Society for Surgery of the Alimentary Tract, Phoenix, AZ, 5/2014 Utilization of Institutional ACS-NSQIP process for improving Surgical Wound Classification, American College of Surgeons-National Surgical Quality Improvement Program Annual Meeting, New York, NY, 7/2014 Evaluating Attitudes Toward and Application of Mechanism to Augment the Liver in North and South America (MALINSA Survey), First ALPPS World Consensus Conference, Hambrug, Germany, 2/2015 Evaluating Attitudes Toward And Application of Mechanisms to Augment the Liver in North and South America (The MALINAS Survey)/Oral, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, FL, 3/12/2015 Thomas A. Aloia, M.D., F.A.C.S. Page 42 of 52 Introperative Airleak Test Prevents Post-Hepatectomy Bile Leak/Video, Americas Hepato- Pancreato-Biliary Association Annual Meeting, Miami, FL, 3/12/2015 Minimally Invasive Partial Right Hepatectomy with Transdiaphragmatic Right Lower Lobe Lung Resection for Colorectal Liver Metastases/Video, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, FL, 3/12/2015 Total Laparoscopic Central Pancreatectomy with Pancreaticogastrostomy for High Risk Cystic Neoplasm/Video, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, FL, 3/12/2015 Transthoracic Port Placement Increases Safety of Total Laparoscopic Posterior Sectionectomy/Video, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, FL, 3/12/2015 Measuring the Impact of Enhanced Recovery in Liver Surgery Using Patient Reported Functional Outcomes, Electronic Residency Application Service World Congress, Washington, DC, 5/10/2015 Collaborative Relationships: Key to a Successful Development of a NSQIP-based Head and Neck Oncoplastic Surgery Database, American College of Surgeons-National Surgical Quality Improvement Program Annual Meeting, San Diego, CA, 7/2015 Comparison of SCR-Coded versus Clinically Documented Postoperative Pneumonia Cases in a Large Multispecialty Cancer Center, American College of Surgeons-National Surgical Quality Improvement Program Annual Meeting, San Diego, CA, 7/2015 Enhanced Recovery Protocols for Gastrointestinal Surgery: The Surgical Multimodal Accelerated Recovery Trajectory (SMART) Approach, American College of Surgeons Annual Meeting, Chicago, IL, 10/5/2015 Patient Reported Outcomes Accurately Measure the Value of Enhanced Recovery Program in Liver Surgery, Western Surgical Association Annual Meeting, Napa Valley, CA, 11/9/2015 Preoperative cholangitis and liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma, Western Surgical Association Annual Meeting, Napa Valley, CA, 11/9/2015 Clarke CN, Patel S, Day R, Aiss MA, Avaloa Monetes De Oca G, George S, Sweeney C, Grubbs EG, Bednarksi BK, Lee JE, Skibber JM, Aloia TA. Use of a Standardized Electronic Tool Improves Compliance Accuracy and Efficiency of Patient Handoffs, Academic Surgical Congress, Phoenix, AZ, 2/2/2016 Perioperative Evaluation of Medical Comorbidities at a Comprehensive Cancer Center, The University of Texas MD Anderson 4th State of the Science Cancer Survivorship Research Symposium, Houston, TX, 2/4/2016 Serum Brain Natriuretic Peptide in the perioperative management of volume status inpatients post hepatectomy, IHPBA World Congress, Sao Paulo, Brazil, 4/21/2016 RAS Mutation Status Impacts Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases, The Society for Surgery of the Alimentary Tract, San Diego, CA, 5/2016 A Nomogram to Predict Hypertrophy of Liver Segments 2 and 3 After Right Portal Vein Embolization, Society for Surgery of the Alimentary Tract_57th Annual Meeting, San Diego, CA, 5/24/2016 NSQIP Benefits: The Improvement Beyond Surgical Care, American College of Surgeons NSQIP Annual Conference, San Diego, CA, 7/2016 Perioperative Assessment Improves 30-day Outcomes for Patients with Poor Functional Status or Dyspnea: An Analysis of Institutional NSQIP Data, American College of Surgeons NSQIP Annual Conference, San Diego, CA, 7/2016 Thomas A. Aloia, M.D., F.A.C.S. Page 43 of 52 CT Imaging Does Not Increase the Risk of Secondary Malignancy in Patients with Colorectal Liver Metastases, Western Surgical Association Annual Meeting, San Diego, CA, 11/7/2016 Overall Body Composition and Sarcopenia are Associated with Poor Liver Regeneration Following Portal Vein Embolization, Western Surgical Association Annual Meeting, San Diego, CA, 11/7/2016 Sarcopenic Obesity Predicts Poor Outcome After Hepatectomy for Colorectal Liver Metastases, Western Surgical Association Annual Meeting, San Diego, CA, 11/7/2016 Sarcopenic obesity predicts poor outcome after hepatectomy for colorectal liver metastases, Academic Surgical Congress, Las Vegas, NV, 2/6/2017 Braf mutation is not a contraindication to resection of colorectal liver metastases, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 Extended pharmacologic thromboprophylaxis in liver surgery is safe and effective, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 Hand-assisted minimally invasive hepatectomy for malignant indications is superior to the totally laparoscopic approach, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 Laparoscopic Glissonean pedicle transection method (Takasaki) for negative fluorescent counterstaining of Segment 6, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 Multi-institutional Analysis of Frequency, Risk Factors and Outcomes for 537 Simultaneous Pancreatectomy/Hepatectomy Procedures, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, FL, 3/2017 Overall body composition and sarcopenia are associated with poor liver regeneration following portal vein embolization, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 Reduction of cardiopulmonary-renal complications with serum brain natriuretic peptide-guided volume status management in post hepatectomy patients, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 Sarcopenic obesity predicts poor outcome after hepatectomy for colorectal liver metastases, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 Want to know the best way to take care of a hepatectomy patient? Just ask them, Americas Hepato-Pancteato-Biliary Association Annual Meeting, Miami, FL, 3/2017 For patients with hepatocellular carcinoma, perioperative transfusion is a covariate for short term morbidity and mortality but does not impact longterm outcomes, Society for Surgery of the Alimentary Tract Annual Meeting, Houston, TX, 5/2017 Longterm survival among mismatch repair deficient cholangiocarcinomas with lynch syndrome, Society for Surgery of the Alimentary Tract Annual Meeting, Houston, TX, 5/2017 Portal vein embolization reduces postoperative hepatic insufficiency associated with hepatic atrophy caused by extensive chemotherapy, Society for Surgery of the Alimentary Tract Annual Meeting, Houston, TX, 5/2017 Reresection of a positive pancreatic margin is associated with prolonged survival among patients with pancreatic cancer treated with preoperative therapy and pancreaticoduodenectomy, Society for Surgery of the Alimentary Tract Annual Meeting, Houston, TX, 5/2017 A Qualitative Study for Identifying Symptom Burden Post Liver Surgery: MDASI-HEP Development, ERAS Society World Congress, Lyon, France, 5/10/2017 Thomas A. Aloia, M.D., F.A.C.S. Page 44 of 52 Multi-institutional Analysis of Frequency, Risk Factors and Outcomes for 537 Simultaneous Pancreatectomy/Hepatectomy Procedures, European-African Hepato-Pancreato-Biliary Association 12th Biennial Meeting, Mainz, Germany, 5/23/2017 Circulating tumor DNA (ctDNA) utilizing a high-sensitivity panel detects minimal residual disease post liver hepatectomy and predicts disease recurrence, American Society of Clinical Oncology (ASCO) Annual Meeting, Surgical Oncology, Chicago, IL, 6/3/2017 Multi-institution Analysis of Infection Control Practices Identifies the Subset Associated with Best Surgical Site Infection Performance: A Texas Alliance for Surgical Quality Collaborative Project, American College of Surgeons Quality and Safety Conference, New York, NY, 7/22/2017 Multi-institution Analysis of Infection Control Practices Identifies the Subset Associated with Best Surgical Site Infection Performance: A Texas Alliance for Surgical Quality Collaborative Project, American College of Surgeons Quality and Safety Conference, New York, NY, 7/22/2017 A novel infection control bundle reduces surgical site infections after hepatectomy and pancreatectomy, Poster, American College of Surgeons Quality and Safety Conference, New York, NY, 7/23/2017 Evaluating Mentorship and Onboarding through Assessment of Patient Outcomes by Attending Surgeons Seniority Using ACS-NSQIP Data, American College of Surgeons Quality and Safety Conference, New York, NY, 7/24/2017 Percutaneous accessory bilioenteric neoanastomosis creation aided by the use of cone-beam computed tomography, Poster, Cardiovascular and Interventional Radiological Society of Europe, Copenhagan, Denmark, 9/16/2017 An Enhanced Recovery Program in Liver Surgery Improves Overall and Recurrence-Free Survivals, Association of Women Surgeons, San Diego, CA, 10/22/2017 A Proactive Outreach Intervention that Reduces Readmission after Hepatectomy, Oral, American College of Surgeons Clinical Congress, San Diego, CA, 10/23/2017 Evaluating Mentorship and Onboarding through Assessment of Patient Outcomes by Attending Surgeon Seniority Using ACS-NSQIP Data, American College of Surgeons Clinical Congress, San Diego, CA, 10/25/2017 Evaluating Mentorship and Onboarding through Assessment of Patient Outcomes by Attending Surgeon Seniority Using ACS-NSQIP Data, American College of Surgeons Clinical Congress, San Diego, CA, 10/25/2017 Multi-institution Analysis of Infection Control Practices Identifies the Subset Associated with Best Surgical Site Infection Performance: A Texas Alliance for Surgical Quality Collaborative Project, American College of Surgeons Clinical Congress, San Diego, CA, 10/25/2017 Reviewing the Review: Assessment of the Peer-Review Process in Surgical Journal, American College of Surgeons Clinical Congress, San Diego, CA, 10/25/2017 Enhancing NPO Compliance with Clear Content, Timing, and Communication Maintains Patient Safety and Improves OR Utilization: A Patient Education Intervention, Poster, The International Society for Quality in Health Care, 34th Conference, London, England, United Kingdom, 11/1/2017 An Enhanced Recovery Program in Liver Surgery Improves Overall and Recurrence-Free Survivals, Western Surgical Association, Scottsdale, AZ, 11/5/2017 Defining the cost savings benefit of enhanced recovery, Western Surgical Society Annual Meeting, Scottsdale, AZ, 11/5/2017 Lee AJ, Chiang Y, Concrad CC, Chun YS, Lee JE, Aloia TA, Vauthey JN, Tzeng CW. National Trends and Predictors of Adequate Nodal Sampling for Resectable Gallbladder Adenocarcinoma, Academic Surgical Congress, Jacksonville, FL, 2/1/2018 Thomas A. Aloia, M.D., F.A.C.S. Page 45 of 52 Vicente D, Loehrer A, Fisher S, Skibber J, Grubbs EG, Aloia TA. Surgical Trainee Attitudes Towards Safety Event Reporting, Academic Surgical Congress, Jacksonville, FL, 2/1/2018 Mizuno T, Goumard C, Okuno M, Asare EA, Krampitz GW, Aloia TA, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Nagino M and Conrad C. Indocyanine Green Fluorescence Counterstaining for Anatomic Laparoscopic Partial Splenectomy, e-Poster, Americas Hepato- Pancreato-Biliary Association, Miami, FL, 3/7/2018 Simoneau EB, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Conrad C, Kim M, Katz MH and Tzeng CD. Pancreaticuduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma: Video Session, Americas Hepato-Pancreato-Biliary Association, Miami, FL, 3/9/2018 Marcus RM, Fuentes DT, Lillemoe HA, Qayyum A, Aloia TA. Quantitative CT Imaging Features Correlate with Colorectal Cancer Liver Metastases (CLM) Mutational Status, Americas Hepato-Pancreato-Biliary Association, Miami, FL, 3/9/2018 Okuno M, Goumard C, Kopetz S, Simoneau EB, Mizuno T, Omichi K, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA and Conrad C. Loss of Muscle Mass during Preoperative Chemotherapy Predicts Worse Recurrence-Free Survival in Patients with Resectable Colorectal Liver Metastases, Americas Hepato-Pancreato-Biliary Association, Miami, FL, 3/11/2018 Vega EA, Vinuela E, Sanhueza M, Mege RM, Diaz C, Aloia TA, Chun YS, Tzeng CD, Okuno M, Goumard C, Simoneau EB, Lee JE, Vauthey JN and Conrad C. Positive Cystic Duct Stump at Index Cholecystectomy in Incidental Gallbladder Cancer is a Strong Negative Prognosticator even in Patients without Residual Disease at Oncologic Re-resection, Americas Hepato-Pancreato-Biliary Association, Miami, FL, 3/11/2018 Detailed Outcomes Analysis of Over 1500 Patients Determines the Safety and Efficacy of Enhanced Recoevery (ER) Protocols in Major Oncologic Surgery, Society of Surgical Oncology Annual Meeting, Chicago, IL, 3/22/2018 Evaluating Faculty Mentorship and Onboarding through Assessment of Patient Outcomes by Surgeons Seniority, Society of Surgical Oncology Annual Meeting, Chicago, IL, 3/22/2018 Safety and Efficacy of Liposomal Bupivacaine in Patients Undergoing Lymph Node Dissection for Melanoma, Society of Surgical Oncology Annual Meeting, Chicago, IL, 3/22/2018 SMAD4 Gene Mutation is Associated with Higher Incidence of Peritoneal Involvement in Unresectable Metastatic Colorectal Cancer, Society of Surgical Oncology Annual Meeting, Chicago, IL, 3/22/2018 The Impact of Turmor Genomic Profile on the Effectiveness of Adjuvant Chemotherapy in Resectable Intrahepatic Cholangiocarcinoma (ICC), Society of Surgical Oncology Annual Meeting, Chicago, IL, 3/22/2018 Tumor Differentiation Impacts Survival in Pancreatic Adenocarcinoma Patients Receiving Preoperative Therapy, Society of Surgical Oncology Annual Meeting, 3/22/2018 validation of AJCC 8 Staging System and Prognostic Value of Lymph Node Ratio for Resectable Pancratic Adenocarcinoma after Neoadjuvant Therapy, Society fo Surgical Oncology Annual Meeting, Chicago, IL, 3/22/2018 Vicente D, Patino M, Marcus RK, Lillemoe H, Vauthey JN, Cata J, Aloia TA. Pre- and Postoperative Characterization of Established and Novel Biomarkers In Patients Undergoing Hepatobiliary Surgery, Society for Surgery of the Alimentary Tract, Washington, DC, 6/4/2018 Process Development for Enhanced Recovery in Medical Oncology, e-Poster, Multinational Association of Supportive Care in Cancer (MASCC/ISOO), Vienna, Austria, 6/28/2018 Seminar Invitations from Other Institutions Thomas A. Aloia, M.D., F.A.C.S. Page 46 of 52 Colorectal liver metastasis: Synchronous vs Metachronous Surgical Resection, 5th Annual Updates on Breakthroughs in Hematology and Oncology, Siriraj Hepatopancreatobiliiary Forum, Bangkok, Thailand, 8/28/2015 Colorectal Liver Metastasis: Synchronous vs. Metachronous Surgical Resection, 1st MD Anderson-Siriraj HPB Forum, Bangkok, Thailand, 8/28/2015 Current Management of pNET: Surgical Management, 1st MD Anderson-Siriraj HPB Forum, Bangkok, Thailand, 8/28/2015 Lectureships and Visiting Professorships Recent Advances in the Multidisciplinary Treatment of Pancreatic and Hepatic Malignancies, University of Arizona, Department of Surgery Grand Rounds, Tucson, AZ, 2/2/2005 ACS-ANZ Traveling Fellow Lecture: A Novel Functional Staging System for HCC, ANZ Royal College of Surgeons Annual Meeting, Adelaide, Australia, 5/4/2011 Hepatic Colorectal Metastasis, AHPBA North South Traveling Fellow Lecture, Clinica Alemana and Pontificia Universidad Catolica De Chile, Santiago, Chile, 1/10/2013 Colorectal Cancer and Liver Metastasis for the Community Surgeon and Oncologist, Virginia Mason Medical Center, Grand Rounds, Seattle, WA, 3/1/2014 Is Perfection the Goal in HPB Surgery?, Cooper University Medical Center, Department of Surgery Grand Rounds, Camden, PA, 4/8/2014 Hepatic Resection for Metastatic Colorectal Malignancy: How MD Anderson Personalizes Eligibility, Stony Brook University Hospital, Department of Surgery Grand Rounds, Stony Brook, NY, 4/9/2014 Enhanced Recovery, Washington University at St. Louis Medical Center, Surgery/Anesthesia Grand Rounds, St. Louis, MO, 9/15/2014 Is Perfection the Goal in HPB Surgery?, Washington University School of Medicine, Department of Surgery Grands, Surgery, St. Louis, MO, 9/16/2014 Quality in HPB Surgery, Washington University at St. Louis Medical Center, Residents Conference, St. Louis, MO, 9/16/2014 Starting Your Practice, Washington University at St. Louis Medical Center, Residents Conference, St. Louis, MO, 9/16/2014 Surgical Quality Improvement: Is Zero Complications the Goal?, James Foster Surgical Society Leadership, Farmington, CT, 10/23/2015 ERAS Team Challenge: The Surgeon’s Perspective, The University of New Mexico Health Sciences Center, Grand Rounds, Surgery, Albuquerque, NM, 11/12/2015 Patient Safety, Quality, and Provider Morale, The James Cancer Hospital, Ohio State University, Grand Rounds, Colombus, OH, 3/30/2016 How to Start Your Practice: Resident/Fellow Conference, Mayo Clinic, Department of Surgery, Scottsdale, AZ, 4/4/2016 Patient Safety, Quality, and Provider Morale, Mayo Clinic, Department of Surgery, Scottsdale, AZ, 4/4/2016 Enhanced Recovery in Surgery: The Surgeon’s Perspective, Mt. Sinai Medical Center, Combined Anesthesia/Surgery Grand Rounds, New York, NY, 11/2/2016 Enhanced recovery in liver surgery, The Methodist Hospital Surgery Grand Rounds, Houston, TX, 2/2017 Enhanced recovery: How to build the team, Advocate Healthcare, Chicago, IL, 3/2017 Other Presentations at State and Local Conferences Thomas A. Aloia, M.D., F.A.C.S. Page 47 of 52 Utility of radiographic evaluation for patients with stage III melanoma diagnosed by positive sentinel lymphadenectomy, The University of Texas MD Anderson Cancer Center, Trainee Recognition Day, 2004 Pre-transplant Management and Doing a Transplant, Baylor College of Medicine, Liver Center Grand Rounds, Houston, TX, 10/16/2006 Hepatobiliary Surgery: From Minimally to Maximally Invasive, Baylor College of Medicine, Pediatric Surgery Grand Rounds, Houston, TX, 11/11/2006 Neoadjuvant Chemotherapy for Colorectal Liver Metastases, Baylor College of Medicine, General Surgery Grand Rounds, Houston, TX, 1/3/2007 Current Management of Hepatocellular Carcinoma, The Methodist Hospital, Surgery Grand Rounds, Houston, TX, 10/4/2007 Phenotypic and Genotypic Similarities of Renal Cell Carcinoma and Hepatocellular Carcinoma, The Methodist Hospital, Genitourinary Oncology Program, Houston, TX, 11/20/2007 The Role of Local International Therapies in the Treatment of Patients with Transplantable Hepatocellular Carcinoma, The University of Texas MD Anderson Cancer Center, Liver Tumor Study Group, Houston, TX, 12/16/2008 NSQIP Update on Vascular Surgery, The Methodist Hospital Vascular Surgery Grand Rounds, Houston, TX, 2/25/2009 Cardiovascular Case Conference, The Methodist Hospital Vascular Surgery Grand Rounds, Houston, TX, 4/16/2009 National Healthcare Reform Starts Here, The Methodist Hospital Surgery Grand Rounds, Houston, TX, 6/18/2009 NSQIP, The Methodist Hospital Surgery Grand Rounds, Houston, TX, 3/11/2010 NSQIP Update on General Surgery, The Methodist Hospital Surgery Grand Rounds, Houston, TX, 5/12/2010 Downstaging Hepatocellular Carcinoma, The Methodist Hospital International Lecture, Houston, TX, 6/1/2010 Resections and Liver Transplants for Neuroendocrine Tumor Patients, The University of Texas MD Anderson Cancer Center NET Patient Education Day, Houston, TX, 11/11/2011 Obstructive Jaundice Due to Malignant Biliary Disease, Citizens Medical Center, Victoria, TX, 5/16/2012 Methods to Improve Resectability, The University of Texas MD Anderson Cancer Center, Interventional Radiology Conference, Houston, TX, 5/23/2012 Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: Analysis of 5,651 NSQIP patients, The University of Texas MD Anderson Cancer Center, Trainee Recognition Day, Houston, TX, 6/15/2012 Creating a Culture That Inspires Quality, American College of Surgeons Health Care Quality Forum, Houston, TX, 9/10/2012 Implementing a Surgical Safety Checklist, University of Texas MD Anderson Cancer Center Celebrating Improvement Program, Houston, TX, 10/11/2012 Improving Surgical Wound Classification, University of Texas MD Anderson Cancer Center Celebrating Improvement Program, Houston, TX, 10/11/2012 Preoperative Medical Evaluation, The University of Texas MD Anderson Cancer Center, GIM Research Clinical Meeting, Houston, TX, 10/25/2012 Preoperative Medical Evaluation, General Internal Medicine Clinical & Research CME Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 11/25/2012 Thomas A. Aloia, M.D., F.A.C.S. Page 48 of 52 ACS NSQIP and Perioperative Risk Assessment, Surgical Grand Rounds, United Regional Hospital, Wichita Falls, TX, 12/17/2012 Tumor Board on Colorectal Cancer, The University of Texas MD Anderson Cancer Center, Office of Global Academic Programs, Houston, TX, 3/22/2013 Managing Liver Metastasis/Video Conference, Cancer Center of SE Texas, Port Arthur, TX, 3/25/2013 National Surgical Quality Improvement Program (NSQIP), The University of Texas MD Anderson Cancer Center, Physicians Relations, Houston, TX, 3/25/2013 Laparoscopic Liver Resection, Midland Memorial Hospital, Midland, TX, 6/12/2013 National Surgical Quality Improvement Program (NSQIP), The University of Texas MD Anderson Cancer Center, Quality Officers Committee, Houston, TX, 6/17/2013 National Surgical Quality Improvement Program (NSQIP), The University of Texas MD Anderson Cancer Center, Mandatory Federal Readiness Committee, Houston, TX, 6/18/2013 National Surgical Quality Improvement Program (NSQIP), The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Safety and Quality Retreat, Houston, TX, 6/20/2013 Implementing a Surgical Safety Checklist, The University of Texas MD Anderson Cancer Center Celebrating Improvement Poster Reception, Houston, TX, 10/23/2013 NSQIP at MD Anderson: A Tool for Performance Improvement, The University of Texas MD Anderson Cancer Center, Division of Surgery Grand Rounds, Houston, TX, 10/23/2013 Measuring the Value of EHR Implementation, The University of Texas MD Anderson Cancer Center, Executive Core Committee, Houston, TX, 1/29/2014 Measuring the Value of EHR Implementation, The University of Texas Cancer Center, Ad Hoc Quality Committee, Houston, TX, 2/11/2014 What’s on the Horizon for the Division of Surgery, The University of Texas MD Anderson Cancer Center, Division of Surgery Grand Rounds, Houston, TX, 2/12/2014 Measurement and Reporting of Cancer Surgery Outcomes, Midland Memorial Hospital, Midland, TX, 7/9/2014 Monitoring Symptomatic and Functional Recovery in Peri-operative Care, Division of Internal Medicine Grand Rounds, Houston, TX, 11/13/2014 Bile Duct and Gallbladder Cancer, HPB Fellows Educational Conference, Houston, TX, 11/19/2014 Surgical Continuous Quality Improvement, The University of Texas MD Anderson Cancer Center, Institute for Healthcare Improvement, Houston, TX, 3/5/2015 EHR Value Metrics, The University of Texas MD Anderson Cancer Center, Electronic Health Record Grand Rounds, Houston, TX, 7/11/2016 Enhanced Recovery in Cancer Care, The University of Texas MD Anderson Cancer Center, Division of Cancer Medicine Grand Rounds, Houston, TX, 7/19/2016 Texas Alliance for Surgical Quality: Wound Infection Practices and Outcomes in TASQ Hospitals, Texas Surgical Conference, Dallas, TX, 9/30/2016 Safety, Quality and Outcomes in Surgical Oncology, The University of Texas MD Anderson Cancer Center, Surgical Oncology Grand Rounds, Surgical Oncology, Houston, TX, 10/5/2016 Using NSQIP Data for Quality Improvement, The University of Texas MD Anderson Cancer Center, Value-Based Head and Neck Cancer Care, Houston, TX, 11/3/2016 The Emerging Importance of Patient Reported Outcomes, The University of Texas MD Anderson Cancer Center, Cancer Network 3rd Annual Partner Meeting, Houston, TX, 11/9/2016 Thomas A. Aloia, M.D., F.A.C.S. Page 49 of 52 Scholarship Opportunity in Quality Improvement, The University of Texas MD Anderson Cancer Center, Advances in Oncology, Institutional Grand Rounds, Houston, TX, 2/24/2017 Enhanced Surgical Recovery, The University of Texas MD Anderson Cancer Center, Physicians Network, Houston, TX, 3/21/2017 Safety Updates: NSQIP Data and Surgical Safety Checklist, The University of Texas MD Anderson Cancer Center, Division of Surgery Town Hall Meeting, Surgical Onoclogy, Houston, TX, 4/12/2017 Standards in enhanced recovery reporting and quality control metrics: A key to success, TEXMed, Houston, TX, 5/2017 Value based and patient centric care: What does this mean?, TEXMed, Houston, TX, 5/2017 Operative Considerations: Two Surgeon Technique, The University of Texas MD Anderson Cancer Center, Advanced Hepato-Pancreato-Biliary Surgery Course, Houston, TX, 11/9/2017 Ultrasound at MD Anderson: Ultrasound Didactics, The University of Texas MD Anderson Cancer Center, Advanced Hepato-Pancreato-Biliary Surgery Course, Houston, TX, 11/10/2017 Pancreas Didactics: Enhanced Recovery After HPB Surgery, The University of Texas MD Anderson Cancer Center, Advanced Hepato-Pancreato-Biliary Surgery Course, Houston, TX, 11/11/2017 HPB Cases, Society of Surgical Oncology Fellows Institute, Houston, TX, 11/14/2017 Surgical Management of Hilar Cholangiocarcinoma: Resection versus Transplant, Society of Surgical Oncology Fellows Institute, Houston, TX, 11/15/2017 Perioperative strategies to imporve oncological outcomes: Role of RIOT, The University of Texas MD Anderson Cancer Center, 5th Global Conference on Perioperative Care of the Cancer Patient, Global Partners, Houston, TX, 11/29/2017 A Surgeon’s Perspective, The University of Texas MD Anderson Cancer Center, 5th Global Conference on Perioperative Care of the Cancer Patient, Global Partners, Houston, TX, 11/30/2017 Organization of multidisciplinary oncology care of the surgical patient, The University of Texas MD Anderson Cancer Center, 5th Global Conference on Perioperative Care of the Cancer Patient, Global Partners, Houston, TX, 11/30/2017 Advances in the Surgical Managment of Cholangiocarcinoma Transplant, The University of Texas MD Anderson Cancer Center, 2nd Annual Sawyer International Pancreatobiliary Symposium, Houston, TX, 12/2/2017 Enhanced Recovery: From ER to OR, Emergency Medicine Education Series, The University of Texas MD Anderson Cancer Center, Emergency Medicine, Houston, TX, 12/13/2017 The Role of PROs in patient-centered value-driven care, The University of Texas MD Anderson Cancer Center, Internal Medicine/Cancer Survivorship Grand Rounds, Houston, TX, 12/15/2017 PROFESSIONAL MEMBERSHIPS/ACTIVITIES Professional Society Activities, with Offices Held National and International American College of Surgeons Member, 1997-present David C. Sabiston Surgical Society Member, 2003-present American Society of Clinical Oncology Member, 2004-present Americas Hepato-Pancreato-Biliary Association Member, 2005-present Thomas A. Aloia, M.D., F.A.C.S. Page 50 of 52 Association Francaise de Chirurgie Member, 2005-2007 Society of Surgical Oncology Member, 2006-present AJCC Cancer Staging Committee: Hepatobiliary Subcommittee: Intrahepatic Cholangiocarcinoma Disease Site Member, 2007-present American Society of Transplant Surgeons Member, 2007-2011 Association of Academic Surgeons Member, 2007-2013 Society for Surgery of the Alimentary Tract Member, 2007-present Americas Hepato-Pancreato-Biliary Association Research Committee Member, 2008-2012 International Liver Transplant Society: Vanguard Committee Member, 2009-2011 Association for Academic Surgery Ethics Committee Member, 2010-2012 Society for Surgery of the Alimentary Tract Maintenance of Certificate (MOC) Committee Member, 2010-2013 Society of American Gastrointestinal and Endoscopic Surgeons Member, 2010-present Society of Surgical Oncology Clinical Affairs Committee Member, 2010-2011 Americas Hepato-Pancreato-Biliary Association Development Committee Vice-Chair, 2011-2013 International Hepato-Pancreato-Biliary Association Member, 2011-present Society of University Surgeons Member, 2011-present Western Surgical Association Member, 2011-present AHPBA Program Directors Committee Member, 2012-present Americas Hepato-Pancreato-Biliary Association Program Committee Vice-Chair, 2013-2014 Society for Surgery of the Alimentary Tract (SSAT) Representative to the Fellowship Council Education Committee Member, 2013-present Society for Surgery of the Alimentary Tract Maintenance of Certificate (MOC) Committee Co-Chair, 2013-2014 Society of Surgical Oncology Research Committee Member, 2013-present Society of University Surgeons Executive Council Councilor-At-Large & Fundraising Chair, 2013-2016 Thomas A. Aloia, M.D., F.A.C.S. Page 51 of 52 Society of University Surgeons Foundation Board Councilor-At-Large, 2013-2016 The Fellowship Council Education Curriculum Committee Member, 2013-2015 Americas Hepato-Pancreato-Biliary Association Program Committee Chair, 2014-2015 SAGES SMART Enhanced Recovery Task Force Member, 2014-present SAGES SMART Task Force Co-Chair, 2014-present Society for Surgery of the Alimentary Tract Maintenance of Certificate (MOC) Committee Chair, 2014-2015 Society of University Surgeons Membership Committee Member, 2014-2016 Western Surgical Association Membership Committee Member, 2014 SAGES Open to MIS Committee Member, 6/2014-6/2016 SAGES Development Committee Member, 2015-present Society for Surgery of the Alimentary Tract Diversity and Inclusion Liaison Committee Member, 2015-2017 Society for Surgery of the Alimentary Tract PG/CME Committee Co-Chair, 2015-2016 Society of Surgical Oncology Research Committee Co-Chair, 2015-2017 American Society for Enhanced Recovery Member, 8/2015-present Surgical Biology Club II Member, 9/2015-present AHPBA Conflict of Interest Committee Member, 2016-2018 ASER HPB Committee Co-Chair, 2016-2018 SAGES SMART Enhanced Recovery Task Force Co-Chair, 2016-2017 Western Surgical Association Membership Committee Member, 2016-present Americas HepatoPancreatoBiliary Association Executive Council Member at Large, 3/2016-3/2019 Sociedad Portuguesa de Cirurgia Honorary Member, 3/2016-present Society of Surgical Oncology, Research Committee Chair, 2017-2019 SAGES Quality Committee Co-Chair, 4/2017-present Thomas A. Aloia, M.D., F.A.C.S. Page 52 of 52 Society for Surgery of the Alimentary Tract, Board of Trustees Counselor at Large, 5/2017-5/2020 SAGES HPB/Solid Organ Task Force Committee Member, 7/2017-present SAGES Quality, Outcomes, Safety Committee Co-Chair, 7/2017-7/2019 International Hepato-Pancreato-Biliary Association Development Committee Member, 2018-2020 Local/State Texas Alliance for Surgical Quality NSQIP Collaborative Member, 2015-present Pain Task Force Committee, Houston, TX Member, 4/2018-present UNIQUE ACTIVITIES 1. AJCC Cancer Staging System, 8th Edition, Hepatobiliary Expert Panel, Chicago, IL 2014-present 2. The American Board of Surgery, Examination Consultant to the Surgical Oncology Board, Philadelphia, PA 2014 -present DATE OF LAST CV UPDATE 6/25/2018